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Abstract: Five C-glycosyl functionalized lysine building blocks,
featuring C-glycosidic derivatives of α-rhamnose, α-mannose,
α-galactose, -galactose, and -N-acetyl glucosamine have
been designed and synthesized. These derivatives, equipped
with acid-labile protecting groups, are eminently suitable for
solid-phase synthesis of multivalent glycopeptides. The lysine
building blocks were prepared from C-allyl glycosides that un-
derwent a Grubbs cross-metathesis with an acrylate, followed
Introduction
Carbohydrates are involved in various inter- and intracellular
recognition events and can be recognized by lectins leading
to a row of biological processes. Lectins function as pattern
recognition receptors. In innate immunity, they promote the
secretion of cytokines and in adaptive immunity, they contrib-
ute to endocytosis.[1,2] Examples of these receptors are DC-SIGN
and the mannose receptor, both C-type lectins that are present
on dendritic cells. Since the binding interactions between lec-
tins and their carbohydrate-binding partners are often relatively
weak, strong interactions depend on the multivalent binding.
Therefore, many multivalent carbohydrate structures such as
polymers, glycoconjugates, and dendrimers have been de-
signed, synthesized, and evaluated for the development of new
therapeutics and more efficient vaccine therapies.[2] For in-
stance, mannosylated polymers and peptides have been used
as therapeutics against HIV, SARS, and influenza virus as well as
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by a reduction of the C=C double bond in the resulting α,-
unsaturated esters, and liberation of the carboxylate to allow
condensation with a lysine side chain. The thus obtained C-
glycosides, five in total, were applied in the solid-phase peptide
synthesis (SPPS) of three glycopeptides, showing the potential
of the described building blocks in the assembly of well-defined
mimics of homo- and heteromultivalent glycopeptides and
glycoclusters.
in cancer immunotherapeutic strategies.[3–6] Such multivalent
conjugates can not only be tailored to effectively mimic com-
plex glycan structures,[7–9] but also their physical properties can
be changed and tuned.[4,10,11] Another example is the exploita-
tion of the abundance of the circulating anti-L-rhamnose anti-
bodies in human blood,[12,13] that can be recruited using multi-
valent rhamnose conjugates.[14–18]
We reasoned that the development of automated solid
phase techniques to generate clusters of (different) carbo-
hydrates would be attractive to rapidly assemble multivalent
glycoconjugates.[6] Ponader et al. developed a solid-phase syn-
thesis method to obtain homo- and hetero-multivalent glyco-
oligomers using alkyne-functionalized building blocks function-
alized by a Cu-catalyzed azide-alkyne [2+3] cycloaddition with
mannose, galactose or glucose synthons equipped with an
azide.[19] This approach, however, cannot be used to install dif-
ferent glycan entities and requires “post-assembly” synthetic
steps making the approach overall more elaborate. In addition,
O-glycosides[20] are generated that can be degraded enzymati-
cally. To prevent hydrolysis of the glycosidic linkage, C-glycos-
ides[21,22] have been developed and incorporated into C-glyc-
osyl amino acid building blocks[6,23–26] allowing the online
solid-phase peptide synthesis (SPPS) of glycopeptides.
Here, we report on the development of a methodology for
the generation of a library of C-glycoside functionalized lysine
SPPS building blocks, including α-rhamnose 1, α-mannose 2, α-
galactose 3, -galactose 4, and -N-acetylglucosamine 5 func-
tionalized lysine synthons, as depicted in Figure 1A. These
building blocks have been designed to be suitable for contem-
porary Fmoc-based SPPS chemistry and can be used for the
synthesis of homo- and heteromultivalent glycomimetics. The
synthesis of building blocks 1–5 hinges on the introduction of
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Figure 1. A) Structures of the C-glycoside SPPS building blocks 1–5; B) synthesis of the C-glycosidic SPPS building blocks; PG: protecting group.
an anomeric C-allyl group,[27] cross-metathesis to install a carb-
oxylic acid functionality and condensation with a suitably pro-
tected lysine (See Figure 1B). The monosaccharides are pro-
tected with acid-labile trityl, p-methoxybenzyl, isopropylidene,
and/or benzylidene groups to allow a one-step protocol in the
final stage of the SPPS that simultaneously removes all protect-
ing groups and releases the glycopeptides or glycoclusters from
the resin.
Results and Discussion
The synthesis of the target C-glycosyl lysine building blocks is
depicted in Scheme 1. The preparation of C-rhamnose 6 started
with the treatment of peracetylated rhamnopyranose with allyl-
trimethylsilane under the agency of BF2OTf·OEt2 as Lewis
acid[28] generated in situ from BF3·OEt2 and TMSOTf, which af-
forded the allyl rhamnoside 6 as an inseparable 5:1 α/-mixture.
This mixture was resolved in the following manner. Following
sodium methoxide-mediated deacetylation, treatment of the
mixture of rhamnosyl-C-glycosides with N-bromosuccinimide
led to the corresponding mixture of bromonium ions, as shown
in Figure 2. The nucleophilic attack of the C-2-OH in the -
rhamnoside on the formed bromonium ion occurred rapidly.
The reaction of the C-2-OH in the α-rhamnose, in contrast, is
hampered, because of the requirement to adopt an energeti-
cally unfavorable 4C1 conformation and the formation of the
trans-fused 5,6-bicyclic ring system (see Figure 2). The cyclized
-product and unreacted α-rhamnose could be readily sepa-
rated via column chromatography, giving pure α-compound 7
in 86 % over three steps.[29] Next, triol 7 was alkylated with
p-methoxybenzyl chloride in the presence of sodium hydride
to provide the fully protected C-rhamnoside 8.
Installation of the required carboxylic acid functionality was
achieved by a cross-metathesis with benzyl acrylate under the
influence of Grubbs 2nd generation catalyst to give the α,-
unsaturated ester in excellent yield (Scheme 1B). The double
bond was chemoselectively reduced with NaBH4 and ruthenium
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trichloride.[30,31] Saponification of the ester then set the stage
for the condensation with Fmoc-L-lysine-OMe. Under the influ-
ence of HCTU and DIPEA, C-rhamnose 9 and the lysine building
block were condensed in 80 % yield. Subsequent hydrolysis of
the methyl ester with LiOH at 0 °C gave Fmoc-protected C-
rhamnose-functionalized lysine building block 1 in 25 % yield
over 9 steps.
The first step in the optimized synthesis route[6] towards
mannose building block 2 comprised the C-allylation at the
anomeric position of mannose. Girard et al. achieved a stereo-
selective allylation using a Sakurai-type reaction on per-benzyl-
ated methyl α-D-mannopyranoside.[32] However, debenzylation
and purification proved to be problematic when performed on
a larger scale. Therefore, an alternative procedure was followed
in which per-acetyl-D-mannose was treated with a mixture of
allyltrimethylsilane, BF3·OEt2, and TMSOTf in MeCN to give the
desired allyl mannoside as a 4.2:1 α/ mixture (Scheme 1A).
Known methods[33,34] to separate the α/ mixture of C-allyl
mannose could not be reproduced on a large scale, and there-
fore a procedure, analogous to the one described above for the
rhamnose synthon, was used. The primary alcohol in the crude
α/-C-allyl mannose was protected with a trityl, to produce a
mixture of 10 and 11 (55 % yield over four steps). Next, the two
anomers were treated with N-bromosuccinimide in THF. This led
to the selective formation of the cyclic -anomer that could be
separated from α-C-allyl mannose 11, which was isolated in
91 % yield. Based on our previous synthesis of a mannose-6-C-
phosphonate building block[35] the C-2-OH and C-3-OH were
masked with an isopropylidene ketal, and, next, by the installa-
tion of a p-methoxybenzyl at the C-4-OH to give fully protected
12. This compound was transformed into the required C-man-
nosyl lysine building block following the sequence of reactions
performed for the rhamnose building block. Thus, a cross-
metathesis of 12 with methyl acrylate was followed by a reduc-
tion of the obtained α,-unsaturated ester with NaBH4, and
ruthenium trichloride to give the desired intermediate in 73 %
yield over the two steps. Saponification of the methyl ester us-
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Scheme 1. A) Synthesis of C-allyl building blocks. Reagents and conditions: a) allyltrimethylsilane, BF3·OEt2, TMSOTf, MeCN, 6: 86 %, 22: 58 %; b) i. NaOMe,
MeOH; ii. N-bromosuccinimide, THF, 3 h, then Na2S2O3, 79 % over two steps; c) p-methoxybenzyl chloride, NaH, TBAI, DMF, 80 %; d) i. Ac2O, pyridine, ii.
allyltrimethylsilane, BF3·OEt2, TMSOTf, MeCN; iii. NaOMe, MeOH; iv. TrtCl, Et3N, DMF, 60 °C, 55 % over four steps; e) N-bromosuccinimide, THF, 3 h, 91 %; f ) i.
p-toluenesulfonic acid, 2,2-dimethoxypropane, 93 %; ii. p-methoxybenzyl chloride, NaH, DMF, 97 %; g) allyltrimethylsilane, BF3·OEt2, CH3NO2, 89 %; h) NaOMe,
MeOH, 91 %; i) TrtCl, Et3N, DMF, 60 °C, 79 %; j) p-methoxybenzyl chloride, NaH, DMF, 17: 52 %, 18: 28 %; k) i. tetrachlorophthalic anhydride, NaOMe, Et3N,
MeOH, 50 °C; ii. Ac2O, pyridine, 51 % over two steps; l) AcCl, MeOH, 94 %; m) benzaldehyde dimethylacetal, p-toluenesulfonic acid, DMF/MeCN, 60 °C, 87 %;
n) i. ethylene diamine, EtOH, 90 °C; ii. Ac2O, NaHCO3, THF/H2O, 83 % over two steps; o) p-methoxybenzyl-2,2,2-trichloroacetimidate, TfOH, THF, 78 %; B)
synthesis of C-glycoside-functionalized lysines 1–5. Reagents and conditions: p) i. benzyl acrylate, Grubbs 2nd gen. catalyst, DCM, 50 °C; ii. NaBH4, RuCl3, MeOH,
DCE, 40 °C; iii. LiOH, THF/MeOH/H2O, 40 °C, 9: 89 over three steps; q) i. methyl acrylate, CuI, Grubbs 2nd gen. catalyst, DCE, 50 °C; ii. NaBH4, RuCl3, MeOH, DCE,
45 °C; iii. LiOH, THF/H2O/MeOH or THF/H2O, 40 °C, 13: 70 %, 19: 67 %, 20: 65 %, 27: 68 % over three steps; r) i. Fmoc-L-Lys-OMe, HCTU, DIPEA, DMF; ii. LiOH,
THF/H2O, 0 °C, 71 %, 1: 57 %, 2: 54 %, 3: 41 %, 4: 45 % over two steps; s) i. Fmoc-L-Lys-OMe, HCTU, DIPEA, DMF; ii. LiOH, THF/H2O, then 1 M HCl, then NaHCO3,
Fmoc N-hydroxysuccinimide ester, 5: 91 % over two steps.
Figure 2. Cyclization of C-rhamnose to obtain pure 7.
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ing LiOH yielded acid 13, which was condensed with Fmoc-L-
lysine-OMe under the influence of HCTU and DIPEA. The ob-
tained methyl ester was then treated with LiOH at 0 °C to obtain
to SPPS building block 2 in 17 % yield over 12 steps.
The synthesis of galactose SPPS building blocks 3 and 4
starts with the C-glycosylation of acetyl 2,3,4,6-tetra-O-acetyl--
D-galactopyranose with allyltrimethylsilane. Performing this re-
action in MeCN gave 14 as a 6:1 α/ mixture (98 % yield), while
in nitromethane a 2:1 α/ mixture (89 % yield) was obtained.
Of note, these reactions show, in line with literature prece-
dents,[36,37] that neighbouring group participation of the C-2-O-
acetate is not a decisive factor in determining the stereochemi-
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cal outcome of these reactions. The preference for the forma-
tion of the α-product can be accounted for by the reactivity of
the galactopyranosyl oxocarbenium ion.[38] Deacetylation of 15
with sodium methoxide and subsequent tritylation of the pri-
mary alcohol with TrtCl and Et3N, produced compound 16 as
an inseparable α/ mixture. In this case, treatment with NBS
did not result in a selective cyclization as both the α- and the
-compound underwent the cyclization at the same rate. Fortu-
nately, after alkylation with p-methoxybenzyl chloride, the ano-
mers could be separated by silica gel column chromatography
yielding α-anomer 17 and -anomer 18 in diastereomerically
pure forms. Both anomers were subjected to the previously de-
scribed cross-metathesis-reduction-saponification reaction se-
quence to furnish acids 19 and 20 in good overall yield. The
acids were condensed with Fmoc-L-lysine-OMe in the presence
of HCTU and DIPEA, followed again by carefully hydrolysis with
LiOH at 0 °C, providing galactose SPPS building blocks 3 and 4
in respectively 9 % and 6 % yield over 9 steps.
The last C-glycosyl lysine building block to be synthesized
comprised glucosamine synthon 5. En route to this building
block, a TCP protecting group was installed on glucosamine,
which was followed by acetylation to give donor 21. Fuchss et
al. reported a synthesis of 22 in which they first transformed
acetyl donor 21 into the corresponding α-fluoride, which was
then used to stereoselectively install the C-allyl group.[39] To
shorten the synthesis of 22, donor 21 was used directly for the
C-glycosylation. After substantial optimization of the reaction
conditions, it was found that sonication of 21 with allyltrimeth-
ylsilane (5.0 equiv.), and BF3·OEt2 (5.0 equiv.) and TMSOTf
(1.0 equiv.) delivered the C-glycoside 22 in 58 % yield on a
40 mmol scale. Deacetylation with in situ generated HCl
(0.8 equiv.) gave triol 23 in 94 %. The use of more HCl or the
use of sodium methoxide resulted in lower yields as a result
of the ring-opening of the TCP protecting group. Subsequent
installation of the benzylidene protecting group gave alcohol
Scheme 2. SPPS synthesis of glycopeptides 29, 30, and 32. Reagents and conditions: a) i. 20 % piperidine, DMF; ii. Fmoc SPPS cycle for Lys(α-C-Man)-Lys(-C-
Gal)-Lys(α-C-Gal)-Lys(N3)-Lys(Boc); iii. 20 % piperidine, DMF; b) Ac2O, DIPEA, DMF; c) TFA/TIS/H2O (95:2.5:2.5 v/v/v), 3 h; d) RP-HPLC; e) i. 5, HCTU, DIPEA, DMSO,
50 °C, 2 h; ii. 5, HCTU, DIPEA, DMSO, overnight; iii. 20 % piperidine, DMF f) i. Fmoc SPPS cycle for LEQLESIINFEKLAAAAA; ii. 20 % piperidine, NMP; g) i. 1,
PyBOP, NMM, NMP; ii. 20 % piperidine, NMP; iii. repeat of conditions i. and ii. five more times; h) TFA/TIS/H2O (93:2:5 v/v/v). Yield glycopeptides: 29) 3.4 mg,
5 %; 30) 1.8 mg, 2 %; 32) 2.6 mg, 6 %.
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24 in 87 %. Removal of the TCP protecting group with ethylene
diamine followed by selective N-acetylation gave 25 in 83 %
yield. Alkylation of the C-3-OH was accomplished by treatment
of 25 with p-methoxybenzyl-2,2,2-trichloroacetimidate and a
catalytic amount of TfOH giving 26 in 78 % yield. Subsequently,
cross-metathesis with methyl acrylate, reduction of the result-
ing double bond, and hydrolysis of the obtained methyl ester
led to acid 27 in a 68 % yield over three steps. After coupling
with Fmoc-L-lysine-OMe, the obtained methyl ester was isolated
by crystallization. Selective hydrolysis of the methyl ester in the
fully protected amino acid C-glycoside proved challenging due
to poor solubility. To solve this problem, the reaction was per-
formed at room temperature, while closely monitoring the con-
version with LC-MS. As partial Fmoc cleavage could not be pre-
vented, the mixture was quenched with 1 M HCl and then
treated with NaHCO3 and Fmoc-N-hydroxysuccinimide ester to
reinstall the Fmoc-protecting group. Subsequent precipitation
with Et2O and recrystallization from MeOH/DCM/Et2O gave
SPPS building block 5 in 91 % yield, completing the set of tar-
get compounds in 8 % yield over 13 steps.
With the target C-glycosyl building blocks in hand, we set
out to probe their efficacy in SPPS. To this end, the four C-
glycoside SPPS building blocks (α-Man 2, α-Gal 3, -Gal 4, and
-GlcNAc 5) were used in the synthesis of glycopeptides 29 and
30 (Scheme 2), which also featured a 6-azido lysine, to illustrate
the compatibility with these two functionalities. One of the ma-
jor advantages of the use of the building blocks designed here
for the assembly of glycopeptides is the fact that one does
not have to rely on post-assembly azide-alkyne click-chemistry,
allowing the use of these functionalities for other conjugation
purposes. Thus, using standard Fmoc-SPPS protocols, immobi-
lized peptide 28 was generated carrying an α-Gal, -Gal, and
α-Man appendage. Cleavage of the glycopeptide from the resin
was achieved by treatment with a cocktail of TFA/TIS/H2O
(95:2.5:2.5 v/v/v) for three hours. Triisopropylsilane (TIS) and
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H2O effectively scavenged the cations released upon acidic de-
protection of the glycosyl lysine moieties. After precipitation of
the peptide from Et2O, it was purified by RP-HPLC to give 29
(3.4 mg) in 5 % yield. Elongation of immobilized peptide 28
with building block 5 proved challenging due to the poor solu-
bility of the building block. The use of a condensation cocktail
of 5, HCTU, and DIPEA in DMSO proved effective and after a
double treatment of 28 and ensuing cleavage and RP-HPLC pu-
rification target peptide 30 was obtained in 2 % yield. To illus-
trate the use of the C-rhamnosyl lysine building block in a rele-
vant larger oligopeptide, we functionalized the ovalbumin de-
rived peptide LEQLESIINFEKLAAAAAK, harboring the MHC–I
epitope SIINFEKL, which can be used as a model antigen with
six C-rhamnoses. After an automated synthesis of immobilized
peptide 31, it was elongated at the N-terminus with six
rhamnose-functionalized lysines to obtain the protected resin-
bound conjugate. After TFA/TIS/H2O-mediated cleavage and RP-
HPLC purification, conjugate 32 (2.6 mg) was obtained in a 6 %
yield, showing the applicability of the C-rhamnosyl building
block in the synthesis of the more complex peptides and the
compatibility of the protecting group strategy with common
Fmoc-SPPS for the generation of C-glycosylated peptides.
Conclusion
With the increasing interest in glycosylated polymers, dendrim-
ers, and peptides, more effective tools are required for their
assembly. In line with this, we have here developed glycosyl-
ated lysine building blocks that can be used in (automated)
solid-phase peptide syntheses. Five C-glycosyl lysine SPPS
building blocks, featuring α-rhamnose, α-mannose, α-galactose,
-galactose, and -N-acetyl glucosamine moiety have been syn-
thesized and their application in SPPS is described. The building
blocks were equipped with solely acid-labile protecting groups
to allow deprotection of the moieties, concomitantly with the
release of the peptides from the resin, increasing assembly effi-
ciency. Key steps in the synthesis of the glycosyl amino acids
are the installation of a C-allyl functionality on the carbo-
hydrates, the ensuing Grubbs cross-metathesis with an acrylate
synthon, and the chemoselective reduction of the C=C double
bond in the α,-unsaturated ester. The C-allylation reactions
proceeded to provide mixtures of α- and -anomers. The unde-
sired -anomers of the C-allyl rhamnoside and C-allyl mannos-
ide could be separated from the target α-anomers using a se-
lective cyclization reaction of the -anomer using N-bromosuc-
cinimide. The application of the C-glycosyl lysines was investi-
gated by the synthesis of a model peptide in which the building
blocks were combined with an azido lysine. Although the solu-
bility of the GlcNAc-amino acid initially posed a challenge, con-
ditions have been found to effectively use the building blocks
in an SPPS assembly. The C-rhamnose building block was used
in the assembly of a larger antigenic peptide, containing the
MHC–I epitope, SIINFEKL, to deliver a conjugate that can be
used as a model antigen, functionalized with an antibody tar-
geting rhamnose cluster. The developed protecting group strat-
egy allows one to combine the building blocks with many other
functionalities in the target peptides, such as azide and alkyne
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click handles. The described building blocks will enable the
rapid assembly of libraries of well-defined mimics for homo-
and hetero-oligovalent glycopeptides and glycoclusters and the
chemistry described can be applied to generate other C-glyc-
osyl amino acids, featuring different monosaccharides.
Experimental Section
General Experimental: All reagents were of commercial grade and
used as received unless stated otherwise. Reaction solvents were of
analytical grade and when used under anhydrous conditions stored
over flame-dried 3Å molecular sieves. All moisture and oxygen-
sensitive reactions were performed under an argon atmosphere.
Column chromatography was performed on silica gel (Screening
Devices BV, 40–63 μm, 60 Å). For TLC analysis, pre-coated silica gel
aluminum sheets (Merck, silica gel 60, F254) were used with detec-
tion by UV-absorption (254/366 nm) where applicable. Compounds
were visualized on TLC by staining with one of the following TLC
stain solutions: (NH4)6Mo7O24·H2O (25 g/L), (NH4)4Ce(SO4)4·2H2O
(10 g/L) and 10 % H2SO4 in H2O; bromocresol (0.4 g/L) in EtOH;
KMnO4 (7.5 g/L), K2CO3 (50 g/L) in H2O. Staining was followed by
charring at ca. 150 °C. 1H and 13C NMR spectra were recorded on a
Bruker AV-400 (400/100/162 MHz) spectrometer or a Bruker AV-500
Ultrashield (500/126/202 MHz) spectrometer and all individual sig-
nals were assigned using 2D-NMR spectroscopy. Chemical shifts are
given in ppm (δ) relative to TMS (0 ppm) in CDCl3 or via the solvent
residual peak. Coupling constants (J) are given in Hz. LC-MS analy-
ses were done on an Agilent Technologies 1260 Infinity system with
a C18 Gemini 3 μm, C18, 110 Å, 50 × 4.6 mm column. Absorbance
was measured at 214 nm and 256 nm and an Agilent Technologies
6120 Quadrupole mass spectrometer was used as detector. Peptides
and conjugates were purified with a Gilson GX-281 preparative
HPLC with a Gemini-NX 5u, C18, 110 Å, 250 × 10.0 mm column.
Peptide fragments were synthesized with automated solid-phase
peptide synthesis on an Applied Biosystems 433A Peptide Synthe-
sizer. Optical rotations were measured on an Anton Paar Modular
Circular Polarimeter MCP 100/150. High-resolution mass spectra
were recorded on a Synapt G2-Si or a Q Exactive HF Orbitrap
equipped with an electron spray ion source positive mode. Infrared
spectra were recorded on a Perkin Elmer Spectrum 2 FT-IR.
General Procedure Glycopeptides Synthesis: The automated
solid-phase peptide synthesis was performed on a Protein Technol-
ogies Tribute-UV IR Peptide Synthesizer applying Fmoc based proto-
col starting from Tentagel S RAM resin (loading 0.22 mmol/g). The
synthesis was continued with Fmoc-amino acids specific for each
peptide. The consecutive steps performed in each cycle for HCTU
chemistry: 1) Deprotection of the Fmoc-group with 20 % piperidine
in DMF for 10 min; 2) DMF wash; 3) Coupling of the appropriate
amino acid using a four-fold excess. Generally, the Fmoc amino acid
(1.0 mmol) was dissolved in 0.2 M HCTU in DMF (5 mL), the resulting
solution was transferred to the reaction vessel followed by 0.5 mL
of 0.5 M DIPEA in DMF to initiate the coupling. The reaction vessel
was then shaken for 30 min at 50 °C; 4) DMF wash; 5) capping with
10 % Ac2O in 0.1 M DIPEA in DMF; 6) DMF wash; 7) DCM wash.
Aliquots of resin of the obtained sequences were checked on an
analytical Agilent Technologies 1260 Infinity system with a Gemini
3 μm, C18, 110 Å, 50 × 4.6 mm column. 30 μmol resin was washed
with DMF, DCM and dried after the last synthesis step followed by
a treatment for 180 minutes with 0.6 mL cleavage cocktail of 95 %
TFA, 2.5 % TIS and 2.5 % H2O. The suspension was filtered, the resin
washed with 0.6 mL of the cleavage cocktail, and the combined TFA
solutions were added dropwise to cold Et2O and stored at –20 °C
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overnight. The obtained suspension of the product in Et2O was
centrifuged, Et2O was removed and the precipitant was dissolved
in CH3CN/H2O/tBuOH (1:1:1 v/v/v). Purification was performed on a
Gilson GX-281 preparative RP-HPLC with a Gemini-NX 5u, C18,
110 Å, 250 × 10.0 mm column.
General Procedure Rhamnose-conjugate Synthesis: The synthe-
sis of the peptide components of the constructs was performed as
has been described before.[40] In short, the peptides were synthe-
sized using solid-phase peptide synthesis on a Tentagel S Ac resin
(Rapp, Tübingen) using a Syro II peptide synthesizer (MultiSyntech,
Witten, Germany). Normal couplings (1.5 h – 2 h) were performed
using Fmoc amino acids carrying acid labile side chain protection
groups (where required). Activation of Fmoc amino acids was per-
formed with PyBop and NMM, azidopropionic acid was coupled
using the succinimidyl ester. Fmoc deprotection was performed
with 20 vol.-% piperidine in NMP. Washings were performed with
NMP. Cleavage from the resin and side chain deprotection was per-
formed with TFA containing 5 vol.-% water and 2 vol.-% triethyl-
silane. Purification was performed with rpHPLC. Analysis of the puri-
fied peptide was performed with UPLC-MS (Acquity, Waters) and
showed the expected molecular masses.
3-(2,3,4-Tri-O-acetyl-α/-L-rhamnosyl)-1-propene (6): After co-
evaporating with toluene (4 ×), acetyl 2,3,4-tri-O-acetyl-α/-L-
rhamnopyranoside (44.7 g, 134 mmol, 1.0 equiv.) was dissolved in
dry MeCN (0.25 L) under an argon atmosphere, followed by the
addition of allyltrimethylsilane (44 mL, 0.28 mol, 2.0 equiv.). After
cooling the mixture to 0 °C, BF3·OEt2 (35 mL, 0.28 mmol, 2.0 equiv.)
and TMSOTf (2.3 mL, 13 mmol, 0.10 equiv.) were added and the
reaction was warmed-up to room temperature overnight. Upon
completion determined by TLC analysis, the reaction was cooled to
0 °C and slowly quenched with Et3N. The mixture was diluted with
sat. aq. NaHCO3 and extracted with EtOAc (2 ×). The combined or-
ganic layers were dried with MgSO4, filtered and concentrated in
vacuo. Purification by column chromatography (10 %→16 % EtOAc
in pentane) gave compound 6 (36.2 g, 115 mmol, 86 %, α/ ratio:
5:1) as a yellow oil. Rf: 0.40 (7:2 pentane/EtOAc); 1H NMR (CDCl3,
400 MHz, HH-COSY, HSQC): δ 5.75–5.58 (m, 1H, CH2-CH=CH2), 5.13–
5.07 (m, 2H, H-2, H-3), 5.06–5.00 (m, 1H, CH2-CH=CHH), 4.97–4.85
(m, 2H, H-4, CH2-CH=CHH), 3.88–3.81 (m, 1H, H-1), 3.70–3.61 (m, 1H,
H-5), 2.48–2.38 (m, 1H, CHH-CH=CH2), 2.35–2.23 (m, 1H, CHH-CH=
CH2), 2.01 (s, 3H, Ac), 1.95 (s, 3H, Ac), 1.90 (s, 3H, Ac), 1.12 (d, 3H,
J = 6.3 Hz, CH3-6). 13C-APT NMR (CDCl3, 101 MHz, HSQC): δ = 170.5,
170.3, 170.0 (C=O), 133.0 (CH2-CH=CH2), 118.3 (CH2-CH=CH2), 74.5
(C-1), 71.6 (C-4), 70.5 (C-3), 69.2 (C-2), 68.3 (C-5), 33.8 (CH2-CH=CH2),
21.1, 21.0, 20.8 (CH3 Ac), 17.7 (CH3-6); FT-IR (neat, cm–1): 2983, 2361,
1745, 1371, 1222, 1051, 668; HRMS: [M + Na]+ calcd. for C15H22O7Na:
337.1263, found 337.1264. *Only data given for the α-anomer.
3-(α-L-Rhamnosyl)-1-propene (7): Compound 6 (36.3 g, 115 mmol,
1.0 equiv., α/ ratio: 5:1) was co-evaporated with toluene (3 ×) un-
der argon atmosphere and dissolved in MeOH (0.58 L). Sodium
methoxide (5.4 M in MeOH, 2.2 mL, 12 mmol, 0.1 equiv.) was added
and the solution was stirred for 2 hours, after which TLC analysis
showed complete conversion of the starting material. The reaction
mixture was acidified by the addition of amberlite H+ resin, filtered
and concentrated in vacuo. The obtained residue was co-evapo-
rated with toluene (1 ×) under argon atmosphere and dissolved in
THF (1.2 L). N-bromosuccinimide (10 g, 55 mmol, 0.48 equiv.) was
added and the reaction was stirred for 3 hours, after which the
reaction was quenched with an aqueous solution of Na2S2O3 (4.4 M,
40 mL). The mixture was further diluted with toluene and concen-
trated in vacuo. The crude product was embedded on silica and
purified by column chromatography (2→8 % MeOH in DCM) yield-
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ing compound 7 (14.2 g, 75.4 mmol, 79 %) as a white solid. Rf: 0.24
(9:1 DCM/MeOH); [α]D20 +18.0° (c = 1.0, MeOH); 1H NMR (MeOD,
400 MHz, HH-COSY, HSQC): δ 5.89–5.75 (m, 1H, CH2-CH=CH2), 5.17–
5.03 (m, 2H, CH2-CH=CH2), 3.91–3.82 (m, 1H, H-1), 3.81–3.75 (m, 1H,
H-2), 3.65 (dd, 1H, J = 8.9, 3.4 Hz, H-3), 3.54–3.45 (m, 1H, H-5), 3.40
(t, 1H, J = 8.9 Hz, H-4), 2.54–2.42 (m, 1H, CHH-CH=CH2), 2.38–2.26
(m, 1H, CHH-CH=CH2), 1.24 (d, 3H, J = 6.1 Hz, CH3-6); 13C-APT NMR
(MeOD, 101 MHz, HSQC): δ = 135.9 (CH2-CH=CH2), 117.4 (CH2-CH=
CH2), 78.5 (C-1), 74.3 (C-4), 72.4 (C-3), 72.3 (C-2), 71.0 (C-5), 34.7 (CH2-
CH=CH2), 18.3 (CH3-6); FT-IR (neat, cm–1): 3371, 2977, 2934, 2361,
1644, 1418, 1253, 1140, 1057, 981, 916, 825, 779, 668, 550; HRMS:
[M + Na]+ calcd. for C9H16O4Na: 211.0946, found 211.0944.
3-(2,3,4-Tri-O-p-methoxybenzyl-α-L-rhamnosyl)-1-propene (8):
Compound 7 (1.92 g, 10.2 mmol, 1.0 equiv.) was co-evaporated with
toluene (1 ×) under argon atmosphere and dissolved in DMF
(0.10 L). Sodium hydride (60 % dispersion in mineral oil, 1.47 g,
36.5 mmol, 3.6 equiv.) was added at 0 °C. After 20 minutes, p-meth-
oxybenzyl chloride (5.0 mL, 37 mmol, 3.6 equiv.) and TBAI (0.38 g,
1.0 mmol, 0.1 equiv.) were added. The reaction was warmed-up to
room temperature. After 6 hours, another portion of sodium
hydride (60 % dispersion in mineral oil, 0.40 g, 10 mmol, 1.0 equiv.)
was added and the reaction was stirred overnight. The reaction was
quenched with MeOH at 0 °C, diluted with H2O and extracted with
DCM. The organic layer was dried with MgSO4, filtered and concen-
trated in vacuo. Purification by column chromatography (10→20 %
Et2O in pentane) gave compound 8 (4.4 g, 8.0 mmol, 79 %) as a
white solid. Rf: 0.84 (8:2 pentane/EtOAc); [α]D20 +20.0° (c = 2.0, DCM);
1H NMR (CDCl3, 400 MHz, HH-COSY, HSQC): δ 7.32 (d, 2H, Ar), 7.27
(d, 4H, Ar), 6.93–6.84 (m, 6H, Ar), 5.79–5.66 (m, 1H, CH2-CH=CH2),
5.08–4.98 (m, 2H, CH2-CH=CH2), 4.78 (d, 1H, J = 10.8 Hz, CHH PMB),
4.65–4.49 (m, 5H, 2 × CH2 PMB, CHH PMB), 4.05–3.97 (m, 1H, H-1),
3.79 (s, 9H, 3 × CH3 PMB), 3.73 (dd, 1H, J = 7.9, 3.1 Hz, H-3), 3.70–
3.65 (m, 1H, H-4), 3.62 (t, 1H, J = 3.3 Hz, H-5), 3.60–3.54 (m, 1H, H-
2), 2.42–2.32 (m, 1H, CHH-CH=CH2), 2.30–2.20 (m, 1H, CHH-CH=CH2),
1.34 (d, 3H, J = 6.3 Hz, H-6); 13C-APT NMR (CDCl3, 101 MHz, HSQC):
δ = 159.1 (Cq Ar), 134.2 (CH2-CH=CH2), 130.5, 130.3, 130.2 (Cq Ar),
129.5, 129.5, 129.3, 128.3 (Ar), 116.9 (CH2-CH=CH2), 113.6, 113.6,
113.5 (Ar), 79.5 (C-2), 77.3 (C-3), 74.5 (C-5), 74.0 (CH2 PMB), 72.7 (C-
1), 71.4, 71.1 (CH2 PMB), 69.5 (C-4), 64.4 (CH2 PMB), 55.0 (CH3 PMB),
34.2 (CH2-CH=CH2), 17.9 (C-6); FT-IR (neat, cm–1): 2934, 2836, 2360,
1641, 1612, 1586, 1512, 1464, 1421, 1358, 1302, 1245, 1173, 1079,
1033, 917, 820, 783, 755, 710, 668, 637, 587, 517; HRMS: [M + Na]+
calcd. For C33H40O7Na: 571.2672, found 571.2670.
3-(2,3,4-Tri-O-p-methoxybenzyl-α-L-rhamnosyl)-butanoic Acid
(9): Compound 8 (25.1 g, 45.8 mmol, 1.0 equiv.) and benzyl acrylate
(19.3 mL, 128 mmol, 2.8 equiv.) were co-evaporated with toluene
(1 ×) under argon atmosphere. The mixture was dissolved in DCM
(0.23 L) and the flask was shielded from light with aluminum foil.
Grubbs 2nd gen. catalyst (0.78 g, 0.92 mmol, 0.02 equiv.) was added
and the reaction was continued to reflux overnight at 50 °C. Upon
completion determined by TLC analysis, the reaction mixture was
filtered through Celite® and concentrated in vacuo. Purification by
column chromatography (10→25 % EtOAc in pentane) gave the alk-
ene intermediate (28.9 g, 42.2 mmol, 92 %) as a white solid. The
obtained alkene (15.4 g, 22.6 mmol, 1.0 equiv.) was co-evaporated
with toluene (1 ×) under argon atmosphere and dissolved in DCE
(90 mL). RuCl3 (0.89 g, 4.2 mmol, 0.19 equiv.) was added and the
argon balloon was replaced with an empty balloon. The reaction
was cooled to 0 °C, NaBH4 (2.7 g, 72.3 mmol, 3.2 equiv.) was added,
after which MeOH (9.15 mL) was carefully added. The mixture was
heated to 40 °C for 4.5 hours, subsequently quenched with MeOH
at 0 °C. The reaction mixture was diluted with DCM and washed
with brine (1 ×). The organic layer was dried with MgSO4, filtered
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and concentrated in vacuo. Purification by column chromatography
(1→4 % acetone in DCM) yielded the intermediate (13.3 g,
22.6 mmol, 86 %) as a transparent oil. 22.7 g of the intermediate
(33.2 mmol, 1.0 equiv.) was dissolved in a mixture of THF/MeOH/
H2O (7:2:1 v/v/v, 0.11 L). The reaction was cooled to 0 °C and
LiOH·H2O (3.5 g, 83 mmol, 2.5 equiv.) was added. The reaction was
heated to 40 °C for 4 hours, after which TLC analysis showed full
conversion of the starting material. The reaction mixture was acidi-
fied with 1 M HCl to pH = 4–5 and extracted with DCM (2 ×). The
combined organic layers were dried with MgSO4, filtered and con-
centrated in vacuo. Purification by column chromatography
(1→20 % acetone in DCM + 0.1 % AcOH) addorded the title com-
pound (18.3 g, 31 mmol, 96 %) as a yellow oil. Rf: 0.32 (4:1 DCM/
acetone); [α]D20 +37.0° (c = 1.0, DCM); 1H NMR (CDCl3, 400 MHz, HH-
COSY, HSQC): δ 7.30–7.18 (m, 6H, Ar), 6.90–6.81 (m, 6H, Ar), 4.72 (d,
1H, J = 10.9 Hz, CHH PMB), 4.58–4.48 (m, 5H, 2 × CH2 PMB, CHH
PMB), 3.92–3.85 (m, 1H, H-1), 3.80 (s, 9H, 3 × CH3 PMB ), 3.67 (dd,
1H, J = 7.7, 3.1 Hz, H-3), 3.63–3.56 (m, 1H, H-5), 3.54–3.48 (m, 2H,
H-2, H-4), 2.32 (t, 2H, J = 7.1 Hz, CH2-9), 1.77–1.63 (m, 1H, CHH-8),
1.63–1.51 (m, 2H, CHH-8, CHH-7), 1.47–1.36 (m, 1H, CHH-7), 1.30 (d,
3H, J = 6.3 Hz, CH3-6); 13C-APT NMR (CDCl3, 101 MHz, HSQC): δ =
178.9 (C=O), 159.3, 130.7, 130.6, 130.4 (Cq PMB), 129.8, 129.7, 129.5,
113.9, 113.9 (Ar), 79.7 (C-2), 77.9 (C-3), 75.6 (C-4), 74.2 (CH2 PMB),
73.0 (C-1), 71.8, 71.4 (CH2 PMB), 69.6 (C-5), 55.4 (CH3 PMB), 33.5
(CH2-9), 28.7 (CH2-7), 21.2 (CH2-8), 18.1 (CH3-6); FT-IR (neat, cm–1):
2934, 2836, 1721, 1707, 1611, 1586, 1512, 1463, 1359, 1302, 1245,
1173, 1108, 1077, 1032, 819, 756, 710, 637, 584, 516; HRMS: [M +
Na]+ calcd. for C34H42O9Na: 617.2727, found 617.2736.
Nα-Fmoc-Nε-[butan-4-(2,3,4-tri-O-p-methoxybenzyl-α-L-rhamnos-
yl)-amide]-L-lysine (1): Compound 9 (3.0 g, 5.0 mmol, 1.0 equiv.)
and Fmoc-L-lysine-OMe (2.4 g, 6.3 mmol, 1.3 equiv.) were co-evapo-
rated with toluene (2 ×) under argon atmosphere. The mixture was
dissolved in DMF (25 mL). HCTU (2.49 g, 6.0 mmol, 1.2 equiv.) and
DIPEA (2.6 mL, 15 mmol, 3.0 equiv.) were subsequently added at
0 °C. The reaction was warmed-up to room temperature and stirred
for 5 hours. The reaction was quenched with H2O and diluted with
EtOAc. The organic layer was subsequently washed with 1 M HCl
(2 ×), sat. aq. NaHCO3 (1 ×) and brine (1 ×). The organic layer was
dried with MgSO4, filtered and concentrated in vacuo. Purification
by column chromatography (10→70 % acetone in DCM) gave the
intermediate (3.8 g, 4.0 mmol, 80 %) as a white solid, of which 2.8 g
(2.9 mmol, 1.0 equiv.) was dissolved in THF (40 mL) and cooled to
0 °C. An aqueous solution of LiOH (0.30 M, 19 mL, 5.7 mmol,
2.0 equiv.) was slowly added. After 40 minutes, the solution was
diluted with EtOAc and acidified with 1 M HCl. The aqueous layer
was extracted with EtOAc (2 ×) and the combined organic layers
were dried with MgSO4, filtered and concentrated in vacuo. Purifica-
tion by column chromatography (15→25 % acetone in DCM + 0.1 %
AcOH) afforded the title compound (1.94 g, 2.06 mmol, 71 %) as a
white solid. Rf: 0.26 (4:1 DCM/acetone + 0.1 % AcOH); [α]D20 +39.0°
(c = 1.0, DCM); 1H NMR (CDCl3, 400 MHz, HH-COSY, HSQC): δ 7.76
(d, 2H, J = 7.6 Hz, Ar), 7.62 (t, 2H, J = 7.3 Hz, Ar), 7.43–7.36 (m, 2H,
Ar), 7.35–7.18 (m, 9H, Ar, Ar), 6.91–6.82 (m, 6H, Ar), 5.89 (t, 1H, J =
5.8 Hz, NH), 5.78 (d, 1H, J = 7.9 Hz, NHFmoc), 4.71 (d, 1H, J = 10.9 Hz,
CHH PMB), 4.61–4.46 (m, 5H, 2 × CH2 PMB, CHH PMB), 4.44–4.34 (m,
3H, CH2 Fmoc, CH L-Lys), 4.22 (t, 1H, J = 7.0 Hz CH Fmoc), 3.96–3.88
(m, 1H, H-1), 3.81 (s, 9H, 3 × CH3 PMB), 3.73–3.62 (m, 2H, H-3, H-5),
3.59–3.50 (m, 2H, H-2, H-4), 3.31–3.17 (m, 2H, CH2 ε-L-Lys), 2.16 (t,
2H, CH2-9), 1.95–1.84 (m, 1H, CHH-8), 1.83–1.75 (m, 1H, CHH-8),
1.74–1.64 (m, 1H, CHH-7), 1.64–1.35 (m, 7H, CHH-7, 3 × CH2 /γ/δ-
L-Lys), 1.32 (d, 3H, J = 6.4 Hz, CH3-6); 13C-APT NMR (CDCl3, 101 MHz,
HSQC): δ = 174.2, 173.7 (C=O), 159.4, 159.3, 156.2, 144.0, 143.9,
141.4, 130.5, 130.4, 129.8 (Cq Ar), 129.6, 127.8, 127.2, 125.3, 120.1,
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113.9 (Ar), 79.3 (C-2), 77.3 (C-3), 75.6 (C-4), 74.0 (CH2 PMB), 72.7 (C-
1), 71.8, 71.5 (CH2 PMB), 70.0 (C-5), 67.1 (CH2 Fmoc), 55.4 (CH3 PMB),
53.6 (CH L-Lys), 47.2 (CH Fmoc), 39.1 (CH2 ε-L-Lys), 36.1 (CH2-9), 31.8
(CH2-7), 29.0, 28.7, 22.3, 22.0 (CH2-8, CH2 /γ/δ-L-Lys), 17.9 (CH3-6);
FT-IR (neat, cm–1): 2930, 1719, 1612, 1512, 1451, 1302, 1247, 1174,
1080, 1034, 821, 741; LC-MS: Rt = 9.03 min (Gemini C18, 10–90 %
MeCN, 12.5 min run); ESI-MS (m/z): [M + Na]+ calcd. for
C61H66N2O11Na: 967.4, found 967.4; HRMS: [M + Na]+ calcd. for
C55H64N2O12Na: 967.4357, found 967.4385.
3-(6-O-Trityl-α/-D-mannopyranosyl)-1-propene (10 + 11): D-
Mannose (52.3 g, 302 mmol, 1.0 equiv.) was dissolved in pyridine
(0.43 L) and the reaction mixture was cooled to 0 °C. Acetic an-
hydride (0.20 L, 2.1 mol, 7.0 equiv.) and DMAP (3.69 g, 30.2 mmol,
0.1 equiv.) were added. After stirring for 25 minutes, the solution
was warmed-up to room temperature and stirring was continued
overnight. The mixture was subsequently cooled to 0 °C and
quenched with MeOH. The solution was diluted with EtOAc and
washed with 1 M HCl (5 ×). The organic layer was dried with MgSO4
and concentrated in vacuo. The residue was co-evaporated with
toluene (2 ×), which gave acetyl 2,3,4,6-tetra-O-acetyl-α/-D-
mannopyranoside as a clear oil which solidified on bench in quanti-
tative yield (124 g). The intermediate was co-evaporated with tolu-
ene (2 ×) and dissolved in MeCN (1.20 L) under an argon atmos-
phere. After cooling the mixture to 0 °C, allyltrimethylsilane (95 mL,
0.62 mol, 2.0 equiv.), BF3·OEt2 (0.19 L, 1.5 mol, 4.9 equiv.) and
TMSOTf (11 mL, 62 mmol, 0.2 equiv.) were added, respectively. After
stirring for 30 minutes, the reaction mixture was warmed-up to
room temperature and stirring continued for 3 days. The reaction
mixture was cooled to 0 °C, diluted with EtOAc and quenched with
Et3N to pH 8. The organic layer was washed with sat. aq. NaHCO3
(1 ×), dried with MgSO4, filtered and concentrated in vacuo. Purifica-
tion by column chromatography (10→60 % Et2O in pentane) gave
a mixture (86.3 g) of 3-(α/-D-mannopyranosyl)-1-propene and un-
reacted acetyl 2,3,4,6-tetra-O-acetyl-α/-D-mannopyranoside. After
dissolving the mixture in MeOH (0.60 L), sodium methoxide (5.4 M
in MeOH, 22 mL, 0.12 mol, 0.4 equiv.) was added and the solution
was stirred for 1.5 hours. TLC analysis showed complete conversion
into a lower running spot (Rf = 0.19 (MeOH/DCM: 1:9 v/v) and the
reaction was quenched using amberlite H+ resin to pH 2–3. The
reaction mixture was filtered and concentrated in vacuo, which
gave a mixture of the fully deacetylated intermediates (47.2 g, max.
231 mmol) as an oil. After co-evaporating with dioxane (1 ×) under
an argon atmosphere, the residue was dissolved in DMF (0.77 L).
Trityl chloride (100 g, 348 mmol, 1.5 equiv.) and Et3N (80 mL,
0.57 mol, 2.5 equiv.) were added and the suspension was heated to
60 °C. After stirring for 2.5 h, TLC analysis showed complete conver-
sion of the starting material. The reaction mixture was cooled to
room temperature, diluted with H2O and extracted with EtOAc (2 ×).
The combined organic layers were dried with MgSO4, filtered and
concentrated in vacuo. After purification by column chromatogra-
phy (20→40 % EtOAc in pentane) compounds 10 and 11 (74.5 g,
167 mmol, 55 % over four steps) were obtained as a foam with an
α/ ratio of 4.2:1. Rf: 0.46 (1:4 pentane/EtOAc); See compound 11
for analysis.
3-(6-O-Trityl-α-D-mannopyranosyl)-1-propene (11): A solution of
compound 10 and 11 (31.4 g, 70.3 mmol, 1.0 equiv., α/: 4.2:1) and
N-bromosuccinimide (6.3 g, 35 mmol, 0.5 equiv.) in THF (0.70 L) was
stirred for 2 h. The reaction was quenched by the addition of sat.
aq. Na2S2O3 (0.50 L). After stirring for an additional 10 minutes, the
mixture was further diluted with sat. aq. Na2S2O3 (0.25 L) and ex-
tracted with DCM (1 ×). The organic layer was washed with sat. aq.
NaHCO3 (1 ×), dried with Na2SO4, filtered and concentrated in
vacuo. Purification by column chromatography (10→60 % acetone
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in DCM + 0.1 % Et3N) yielded the title compound (23.1 g,
51.7 mmol, 91 %) as a white foam. Rf: 0.42 (7:3 DCM/acetone);
[α]D25 –18.2° (c = 0.72, CHCl3); 1H NMR (CD3CN, 400 MHz, HH-COSY,
HSQC): δ 7.54–7.44 (m, 6H, Ar), 7.36–7.29 (m, 6H, Ar), 7.29–7.23 (m,
3H, Ar), 6.04–5.90 (m, 1H, CH2-CH=CH2), 5.26–5.11 (m, 2H, CH2-CH=
CH2), 3.88 (ddd, 1H, J = 9.5, 5.4, 2.5 Hz, H-1), 3.71–3.64 (m, 2H, H-2,
H-5), 3.60 (ddd, 1H, J = 9.3, 6.0, 3.5 Hz, H-4), 3.45–3.37 (m, 1H, H-3),
3.25–3.12 (m, 3H, CH2-6, OH), 3.05 (t, 2H, J = 4.6 Hz, 2 × OH), 2.60–
2.51 (m, 1H, CHH-CH=CH2), 2.35–2.27 (m, 1H, CHH-CH=CH2); 13C-
APT NMR (CD3CN, 101 MHz, HSQC): δ = 145.3 (Cq Trt), 136.3 (CH2-
CH=CH2), 129.6, 128.8, 128.0 (Ar), 117.3 (CH2-CH=CH2), 87.2 (Cq Trt),
77.4 (C-1), 74.4 (C-5), 72.5 (C-4), 71.6 (C-2), 69.7 (C-3), 65.1 (CH2-6),
34.4 (CH2-CH=CH2); FT-IR (neat, cm–1): 3402, 3060, 2928, 1708, 1643,
1597, 1490, 1449, 1221, 1073, 1033, 989, 901, 827, 765, 748, 701,
633, 529; HRMS: [M + Na]+ calcd. for C28H30O5Na: 469.1991, found
496.1991.
3-(2,3-O-Isopropylidene-4-O-p-methoxybenzyl-6-O-trityl-α-D-
mannopyranosyl)-1-propene (12): Compound 11 (43.9 g,
98.3 mmol, 1.0 equiv.) was dissolved in 2,2-dimethoxypropane (0.50
L) and cooled to 0 °C. p-Toluenesulfonic acid (2.88 g, 15.1 mmol,
0.15 equiv.) was added and the reaction mixture was stirred for 10
minutes, after which TLC analysis showed complete conversion of
the starting material. The reaction was quenched by the addition
of Et3N (7 mL), diluted with DCM and washed with a mixture of sat.
aq. NAHCO3/brine (1:1, v/v, 1 ×). The organic layer was dried with
Na2SO4, filtered and concentrated in vacuo. Purification by column
chromatography (10→50 % Et2O in pentane + 0.1 % Et3N) gave the
intermediate (44.6 g, 89.1 mmol, 91 %) as a clear oil. After co-evapo-
rating with toluene (2 ×) under an argon atmosphere, the interme-
diate (49.9 g, 102.5 mmol, 1.0 equiv.) was dissolved in DMF (0.50 L)
and cooled to 0 °C. Sodium hydride (60 % dispersion in mineral oil,
4.95 g, 123 mmol, 1.2 equiv.) and p-methoxybenzyl chloride
(17.0 mL, 125 mmol, 1.2 equiv.) were added and the suspension
was warmed-up up to room temperature after 20 minutes. After
stirring at room temperature for an additional hour, TLC analysis
showed complete conversion of the starting material. The reaction
was quenched by the addition of MeOH at 0 °C, diluted with Et2O
and washed with H2O (2 ×). The organic layer was dried with
Na2SO4, filtered and concentrated in vacuo. Purification by column
chromatography (5→20 % Et2O in pentane + 0.1 % Et3N) yielded
the title compound (60.3 g, 99.4 mmol, 97 %) as a clear oil. Rf: 0.63
(pentane/Et2O); [α]D25 +12.7° (c = 0.67, CHCl3); 1H NMR (CD3CN,
400 MHz, HH-COSY, HSQC): δ 7.49–7.44 (m, 6H, Ar), 7.35–7.24 (m,
9H, Ar), 6.96–6.92 (m, 2H, Ar), 6.80–6.75 (m, 2H, Ar), 6.06–5.93 (m,
1H, CH2-CH=CH2), 5.24–5.10 (m, 2H, CH2-CH=CH2), 4.62 (d, 1H, J =
11.0 Hz, CHH PMB), 4.31–4.21 (m, 2H, H-3, CHH PMB), 4.08 (dd, 1H,
J = 6.4, 5.4 Hz, H-2), 3.99–3.92 (m, 1H, H-1), 3.75 (s, 3H, CH3 PMB),
3.70–3.60 (m, 2H, H-4, H-5), 3.31 (dd, 1H, J = 9.9, 2.1 Hz, CHH-6),
3.08 (dd, 1H, J = 9.8, 5.0 Hz, CHH-6), 2.42 (t, 2H, J = 6.9 Hz, CH2-CH=
CH2), 1.46 (s, 3H, CH3 isopropylidene), 1.34 (s, 3H, CH3 isopropylid-
ene); 13C-APT NMR (CD3CN, 101 MHz, HSQC): δ = 160.1 (Cq PMB),
145.1 (Cq Trt), 135.9 (CH2-CH=CH2), 131.3 (Cq PMB), 130.5, 129.6,
128.8, 128.1 (Ar), 117.6 (CH2-CH=CH2), 114.4 (Ar), 109.9 (Cq iso-
propylidene), 87.2 (Cq Trt), 79.2 (C-3), 77.2 (C-2), 76.5 (C-4), 73.7
(C-1), 73.2 (CH2 PMB), 73.0 (C-5), 64.4 (CH2-6), 55.8 (CH3 PMB), 37.4
(CH2-CH=CH2), 28.1, 26.0 (CH3 isopropylidene); FT-IR (neat, cm–1):
2987, 2934, 1613, 1514, 1491, 1449, 1381, 1302, 1247, 1212, 1172,
1069, 1034, 1002, 915, 868, 822, 765, 747, 704, 633, 518; HRMS:
[M + Na]+ calcd. for C39H42O6Na: 629.2879, found 629.2881.
4-(2,3-O-Isopropylidene-4-O-p-methoxybenzyl-6-O-trityl-α-D-
mannopyranosyl)-butanoic Acid (13): Compound 12 (5.7 g,
9.4 mmol, 1.0 equiv.) was co-evaporated with toluene (2 ×) under
an argon atmosphere, before being dissolved in dry DCE (0.10 L).
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Methyl acrylate (2.4 mL, 26 mmol, 2.8 equiv.), CuI (0.28 g, 1.5 mmol,
0.16 equiv.) and Grubbs 2nd generation catalyst (0.32 g, 0.38 mmol,
0.04 equiv.) were added and the flask was covered in aluminum foil.
The suspension was heated to 50 °C and stirred for 48 hours, after
which it was concentrated in vacuo and co-evaporated with toluene
(3 ×). Purification by column chromatography (10→70 % Et2O in
pentane) afforded the intermediate (4.9 g, 7.4 mmol, 1.0 equiv.),
which was co-evaporated with toluene (2 ×) under an argon atmos-
phere and dissolved in dry DCE (37 mL). Two empty balloons were
placed on the flask, followed by the addition of RuCl3 (0.29 g,
1.4 mmol, 0.19 equiv.) and NaBH4 (0.89 g, 24 mmol, 3.2 equiv.) at
0 °C. Methanol (6.0 mL, 0.15 mol, 20 equiv.) was carefully added to
the suspension over 20 minutes, after which the mixture was
warmed-up up to room temperature over 20 minutes. The mixture
was subsequently heated to 45 °C for 4 hours. The reaction mixture
was cooled to room temperature, diluted with brine, filtered
through celite and extracted with DCM (2 ×). The combined organic
layers were dried with Na2SO4, filtered and concentrated in vacuo.
Purification by column chromatography (20→60 % Et2O in pentane)
gave the intermediate (4.6 g, 6.9 mmol, 73 % over two steps), which
was dissolved in a mixture of THF/H2O/MeOH (7:1:2, v/v/v, 35 mL).
LiOH (0.87 g, 21 mmol, 3.0 equiv.) was added and the mixture was
heated to 40 °C for 8 hours, after which TLC analysis showed com-
plete conversion of the starting material. The reaction mixture was
cooled to 0 °C, acidified with 1 M HCl to pH = 6, diluted with H2O
and extracted with DCM (2 ×). The combined organic layers were
dried with Na2SO4, filtered and concentrated in vacuo. The title
compound was obtained (4.3 g, 6.6 mmol, 96 %). Rf: 0.85 (9:1 DCM/
MeOH); [α]D25 +16.0° (c = 0.43, CHCl3); 1H NMR (CDCl3, 400 MHz, HH-
COSY, HSQC): δ 7.51–7.43 (m, 6H, Ar), 7.34–7.20 (m, 9H), 7.01–6.92
(m, 2H, Ar), 6.79–6.71 (m, 2H, Ar), 4.69 (d, 1H, J = 10.9 Hz, CHH PMB),
4.34 (d, 1H, J = 10.9 Hz, CHH PMB), 4.26 (t, 1H, J = 6.9 Hz, H-3), 4.03
(t, 1H, J = 6.5 Hz, H-2), 3.91–3.81 (m, 1H, H-1), 3.79 (s, 3H, CH3 PMB),
3.78–3.65 (m, 2H, H-4, H-5), 3.38 (dd, 1H, J = 9.9, 2.1 Hz, CHH-6),
3.18 (dd, 1H, J = 9.9, 4.9 Hz, CHH-6), 2.43 (t, 2H, J = 7.2 Hz, CH2-9),
2.00 (m, 1H, CHH-8), 1.85–1.63 (m, 3H, CHH-8, CH2-7), 1.50 (s, 3H,
CH3 isopropylidene), 1.38 (s, 3H, CH3 isopropylidene); 13C-APT NMR
(CDCl3, 101 MHz, HSQC): δ = 179.2 (C=O), 159.2, 144.1, 130.2
(Cq Ar), 129.8, 128.9, 127.9, 127.0, 113.7 (Ar), 109.4 (Cq isopropylid-
ene), 86.5 (Cq Trt), 78.8 (C-3), 77.1 (C-2), 75.6 (C-4), 72.9 (C-5), 72.8
(CH2 PMB), 72.6 (C-1), 63.4 (CH2-6), 55.4 (CH3 PMB), 33.8 (CH2-9),
32.0 (CH2-7), 27.8, 25.7 (CH3 isopropylidene), 20.8 (CH2-8); FT-IR
(neat, cm–1): 3058, 2987, 2934, 1707, 1612, 1586, 1513, 1490, 1449,
1381, 1302, 1245, 1216, 1160, 1068, 1034, 1002, 900, 866, 822, 777,
765, 737, 703, 644, 632; HRMS: [M + Na]+ calcd. for C40H44O8Na:
675.29284, found 675.29260.
Nα-Fmoc-Nε-[butan-4-(2,3-O-isopropylidene-4-O-p-methoxy-
benzyl-6-O-trityl-α-D-mannopyranosyl)-amide]-L-lysine (2):
Compound 13 (3.8 g, 5.8 mmol, 1.0 equiv.) and Fmoc-L-lysine-OMe
(2.9 g, 7.0 mmol, 1.2 equiv.) were dissolved in DMF (30 mL). HCTU
(2.9 g, 7.0 mmol, 1.2 equiv.) and DIPEA (3.0 mL, 17 mmol, 3.0 equiv.)
were added and the solution was stirred for 4 hours. The reaction
mixture was diluted with EtOAc and washed with 1 M HCl (1 ×), sat.
aq. NaHCO3 (1 ×), brine (1 ×). The organic layer was dried with
Na2SO4, filtered and concentrated in vacuo. Purification by column
chromatography (2→30 % acetone in DCM) yielded the intermedi-
ate (5.6 g, 5.5 mmol, 95 %) of which 3.05 g (3.00 mmol, 1.0 equiv.)
was dissolved in THF (30 mL) and cooled to 0 °C. An aqueous solu-
tion of LiOH (0.30 M, 20 mL, 6.0 mmol, 2.0 equiv.) was added and
the mixture was stirred vigorously for 30 minutes, after which the
mixture was diluted with EtOAc and acidified by the addition of 1 M
HCl to pH = 3–4. The mixture was washed with brine (1 ×) and the
aqueous layer was extracted with EtOAc (1 ×). The combined or-
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ganic layers were dried with Na2SO4, filtered and concentrated in
vacuo. After purification by column chromatography (1→8 % MeOH
in DCM) the title compound (1.73 g, 1.72 mmol, 57 %) was obtained
as a white foam. Rf: 0.61 (9:1 DCM/MeOH); [α]D25 +20.8° (c = 0.62,
CHCl3); 1H NMR (MeOD, 400 MHz, HH-COSY, HSQC): δ 7.77 (d, 2H,
J = 7.5 Hz, Ar), 7.69–7.63 (m, 2H, Ar), 7.45–7.34 (m, 8H, Ar), 7.33–
7.18 (m, 11H, Ar), 6.95–6.88 (m, 2H, Ar), 6.75–6.68 (m, 2H, Ar), 4.61
(d, 1H, J = 11.0 Hz, CHH PMB), 4.34 (d, 2H, J = 7.0 Hz, CH2 Fmoc),
4.29 (d, 1H, J = 11.1 Hz, CHH PMB), 4.25–4.16 (m, 2H, H-3, CH Fmoc),
4.09 (dd, 1H, J = 9.4, 4.6 Hz, CH L-Lys), 4.01 (t, 1H, J = 6.4 Hz, H-2),
3.81 (dd, 1H, J = 7.7, 5.3 Hz, H-1), 3.75 (s, 3H, CH3 PMB), 3.69 (dd,
1H, J = 9.5, 7.3 Hz, H-4), 3.62–3.55 (m, 1H, H-5), 3.35–3.30 (m, 1H,
CHH-6), 3.11 (t, 2H, J = 6.7 Hz, CH2 ε-L-Lys), 3.05 (dd, 1H, J = 9.9,
5.2 Hz, CHH-6), 2.26–2.16 (m, 2H, CH2-9), 1.98–1.86 (m, 1H, CHH-8),
1.86–1.68 (m, 2H, CHH-8, CHH-7), 1.68–1.56 (m, 3H, CHH-7, 1 × CH2
/γ/δ-L-Lys), 1.50–1.30 (m, 10H, 2 × CH2 /γ/δ-L-Lys, 2 × CH3 isopro-
pylidene); 13C-APT NMR (MeOD, 101 MHz, HSQC): δ = 175.8, 160.7
(C=O), 145.3, 142.6, 131.3 (Cq Ar), 130.8, 130.0, 128.8, 128.2, 128.1,
126.3, 120.9, 114.5 (Cq Ar), 110.5 (Cq isopropylidene), 87.8 (Cq Trt),
80.0 (C-3), 78.4 (C-2), 76.6 (C-4), 74.0 (C-5), 73.8 (C-1), 73.6 (CH2 PMB),
67.8 (CH2 Fmoc), 64.6 (CH2-6), 55.7 (CH3 PMB), 55.4 (CH L-Lys) 48.4
(CH Fmoc), 40.1 (CH2 ε-L-Lys), 36.8 (CH2-9), 32.9 (CH2-7), 30.3, 29.9
(CH2 /γ/δ-L-Lys), 28.0, 25.7 (CH3 isopropylidene), 24.3 (CH2 /γ/δ-L-
Lys), 23.3 (CH2-8); FT-IR (neat, cm–1): 3330, 2934, 1716, 1612, 1513,
1449, 1381, 1302, 1246, 1213, 1179, 1160, 1067, 1033, 1002, 900,
865, 822, 760, 735, 701, 646, 632, 621, 516; LC-MS: Rt = 13.48 min
(Vydac 219TP 5 μm Diphenyl, 10–90 % MeCN, 21 min run); ESI-MS
(m/z): [M + Na]+ calcd. for C61H66N2O11Na: 1025.5, found 1025.4;
HRMS: [M + H]+ calcd. for C61H67O2N11: 1003.47394, found
1003.47380.
3-(2,3,4,6-Tetra-O-acetyl-α/-D-galactopyranosyl)-1-propene
(14): Acetyl 2,3,4,6-tetra-O-acetyl--D-galactopyranose (23.7 g,
60.8 mmol, 1.0 equiv.) was co-evaporated with toluene (2 ×) under
an argon atmosphere and dissolved in CH3NO2 (0.24 L). Allyltri-
methylsilane (20 mL, 0.13 mol, 2.1 equiv.) was added, followed by
the addition of BF3·OEt2 (23 mL, 0.18 mol, 3.0 equiv.) at 0 °C. The
yellow solution was allowed to stir at room temperature for 3 days.
The reaction was quenched by the addition of sat. aq. NaHCO3 at
0 °C, diluted with EtOAc and washed with brine (1 ×). The organic
layer was dried with Na2SO4, filtered and concentrated in vacuo.
Purification by column chromatography (10→50 % Et2O in pentane)
afforded the title compound (20.1 g, 54.0 mmol, 89 %) as a yellow
oil with an α/ ratio of 2:1. Rf: 0.41 (1:1 pentane/Et2O); 1H NMR
(CDCl3, 400 MHz, HH-COSY, HSQC): δ 5.80–5.69 (m, 1H, CH2-CH=
CH2), 5.43–5.38 (m, 1H, H-4), 5.26 (dd, 1H, J = 9.3, 5.0 Hz, H-2), 5.20
(dd, 1H, J = 9.4, 3.2 Hz, H-3), 5.12–5.06 (m, 2H, CH2-CH=CH2), 4.33–
4.25 (m, 1H, H-1), 4.24–4.14 (m, 1H, CHH-6), 4.14–4.01 (m, 2H, H-5,
CHH-6), 2.54–2.38 (m, 1H, CHH-CH=CH2), 2.35–2.21 (m, 1H, CHH-
CH=CH2), 2.11 (s, 3H, CH3 Ac), 2.06 (s, 3H, CH3 Ac), 2.05–2.00 (m, 6H,
2 × CH3 Ac); 13C-APT NMR (CDCl3, 101 MHz, HSQC): δ = 170.7, 170.2,
170.1, 170.0 (C=O), 133.4 (CH2-CH=CH2), 117.8 (CH2-CH=CH2), 71.6
(C-1), 68.4 (C-5), 68.0 (C-2), 67.8 (C-3), 67.7 (C-4), 61.6 (CH2-6), 31.0
(CH2-CH=CH2), 20.9, 20.9, 20.8, 20.8, 20.8 (CH3 Ac); FT-IR (neat, cm–1):
2978, 1740, 1644, 1434, 1369, 1212, 1044, 909, 601; HRMS: [M +
Na]+ calcd. for C17H24O9Na: 395.1318, found 395.1316. *NMR analy-
sis only given for the α-anomer.
3-(α/-D-Galactopyranosyl)-1-propene (15): Compound 14
(20.0 g, 53.8 mmol, 1.0 equiv.) was dissolved in MeOH (0.11 L). So-
dium methoxide (5.4 M in MeOH, 4.0 mL, 22 mmol, 0.40 equiv.) was
added and the solution was stirred for 3 hours, after which it was
acidified by the addition of amberlite H+ resin. The mixture was
filtered and concentrated in vacuo. The title compound (10.0 g,
49.2 mmol, 91 %) was obtained as a yellow foam and used without
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further purification. Rf : 0.13 (9:1 DCM/MeOH); 1H NMR (MeOD,
400 MHz, HH-COSY, HSQC): δ 5.93–5.82 (m, 1H, CH2-CH=CH2), 5.17–
5.06 (m, 2H, CH2-CH=CH2), 4.03–3.93 (m, 2H, H-1, H-2), 3.93–3.85
(m, 1H, H-3), 3.80–3.62 (m, 4H, H-4, H-5, CH2-6), 2.52–2.32 (m, 2H,
CH2-CH=CH2); 13C-APT NMR (MeOD, 101 MHz, HSQC): δ = 136.7
(CH2-CH=CH2), 116.9 (CH2-CH=CH2), 75.6 (C-1), 74.0, 71.9 (C-4, C-5),
70.1 (C-3), 70.0 (C-2), 61.9 (CH2-6), 31.0 (CH2-CH=CH2); FT-IR (neat,
cm–1): 3352, 2919, 1642, 1416, 1073, 914, 515; HRMS: [M + Na]+
calcd. for C9H16O5Na: 227.0895, found 227.0894. *NMR analysis only
given for the α-anomer.
3-(6-O-Trityl-α/-D-galactopyranosyl)-1-propene (16): Trityl
chloride (21 g, 75 mmol, 1.3 equiv.) and Et3N (17 mL, 0.12 mol,
2.5 equiv.) were added to a solution of compound 15 (10.0 g,
48.9 mmol, 1.0 equiv.) in DMF (0.16 L). The mixture was heated to
60 °C overnight. The mixture was diluted with EtOAc and washed
with brine (3 ×). The organic layer was dried with Na2SO4, filtered
and concentrated in vacuo. Purification by column chromatography
(30→100 % EtOAc in pentane) gave the title compound (17.3 g,
38.7 mmol, 79 %). Rf: 0.36 (3:7 pentane/EtOAc); 1H NMR (CD3CN,
400 MHz, HH-COSY, HSQC): δ 7.50–7.44 (m, 6H, Trt), 7.36–7.29 (m,
6H, Trt), 7.29–7.23 (m, 3H, Trt), 6.04–5.87 (m, 1H, CH2-CH=CH2), 5.24–
5.03 (m, 2H, CH2-CH=CH2), 3.96–3.89 (m, 1H, H-1), 3.89–3.83 (m, 1H,
H-5), 3.81–3.72 (m, 2H, H-2, H-4), 3.64–3.53 (m, 1H, H-3), 3.33–3.12
(m, 3H, CHH-6, 2 × OH), 3.11–3.04 (m, 1H, CHH-6), 2.91–2.82 (m, 1H,
OH), 2.52–2.42 (m, 1H, CHH-CH=CH2), 2.39–2.29 (m, 1H, CHH-CH=
CH2); 13C-APT NMR (CD3CN, 101 MHz, HSQC): δ = 145.3 (Cq Trt),
137.0 (CH2-CH=CH2), 129.6, 128.8, 128.0 (Ar), 116.9 (CH2-CH=CH2),
87.3 (Cq Trt), 75.4 (C-1), 71.4 (C-5), 70.8 (C-3), 70.2, 69.7 (C-2, C-4),
64.3 (CH2-6),30.2 (CH2-CH=CH2); FT-IR (neat, cm–1): 3391, 3059, 2929,
1642, 1597, 1490, 1448, 1265, 1222, 1153, 1069, 988, 901, 823, 762,
737, 704, 650, 632, 580, 536; HRMS: [M + Na]+ calcd. for C28H30O5Na:
469.1991, found 469.1988. *NMR analysis only given for the α-ano-
mer.
3-(2,3,4-Tri-O-p-methoxybenzyl-6-O-trityl-α-D-galactopyran-
osyl)-1-propene (17): Triol 16 (16.4 g, 36.8 mmol, 1.0 equiv.) was
co-evaporated with toluene (2 ×) under an argon atmosphere and
dissolved in DMF (0.37 L). Sodium hydride (60 % dispersion in min-
eral oil, 5.3 g, 0.13 mol, 3.5 equiv.) was added at 0 °C over 30 min-
utes. After 1 hour, p-methoxybenzyl chloride (18 mL, 0.13 mol,
3.5 equiv.) and tetrabutylammonium iodide (1.4 g, 3.8 mmol,
0.10 equiv.) were added. Another portion of sodium hydride (60 %
dispersion in mineral oil, 2.3 g, 58 mmol, 1.6 equiv.) was added after
1 hour and the mixture was stirred at room temperature overnight.
The reaction was quenched with MeOH at 0 °C, diluted with Et2O
and washed H2O (3 ×). The organic layer was dried with Na2SO4,
filtered and concentrated in vacuo. Purification by column chroma-
tography (10→30 % Et2O in pentane) gave compound 17 (15.5 g,
19.2 mmol, 52 %) and compound 18 (8.23 g, 10.3 mmol, 28 %).
Rf: 0.26 (7:3 pentane/Et2O); [α]D25 +35.9° (c = 0.44, CHCl3); 1H NMR
(CD3CN, 500 MHz, HH-COSY, HSQC): δ 7.47–7.41 (m, 6H, Ar), 7.34–
7.21 (m, 11H, Ar), 7.09 (dd, 4H, J = 19.9, 8.5 Hz, Ar), 6.90 (d, 2H,
J = 8.6 Hz, Ar), 6.86–6.81 (m, 4H, Ar), 5.87–5.76 (m, 1H, CH2-CH=
CH2), 5.17–5.03 (m, 2H, CH2-CH=CH2), 4.52–4.42 (m, 5H, 2 × CH2
PMB, 1 × CHH PMB), 4.34 (d, 1H, J = 11.2 Hz, CHH PMB), 4.09–4.03
(m, 1H, H-5), 3.91 (dd, 1H, J = 4.3, 3.0 Hz, H-4), 3.82–3.74 (m, 11H,
H-1, H-3, 3 × CH3 PMB), 3.62–3.55 (m, 2H, H-2, CHH-6), 3.17 (dd, 1H,
J = 10.6, 3.2 Hz, CHH-6), 2.45–2.36 (m, 1H, CHH-CH=CH2), 2.36–2.27
(m, 1H, CHH-CH=CH2); 13C-bbdec NMR (CD3CN, 126 MHz, HSQC):
δ = 160.7, 160.6, 160.5, 145.7 (Cq Ar), 136.8 (CH2-CH=CH2), 132.3,
132.1, 130.8, 130.5, 130.2, 129.9, 128.9, 128.1 (Ar), 117.2 (CH2-CH=
CH2), 115.0, 114.9 (Ar), 87.6 (Cq Trt), 77.2 (C-2), 76.8 (C-3), 75.3 (C-4),
74.4 (C-5), 73.4, 73.0 (CH2 PMB), 71.2 (C-1), 62.5 (CH2-6), 56.2 (CH3
PMB), 33.8 (CH2-CH=CH2); FT-IR (neat, cm–1): 2934, 2906, 2836, 1612,
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1586, 1513, 1491, 1464, 1449, 1355, 1302, 1247, 1173, 1091, 1034,
995, 916, 821, 765, 748, 707, 649, 633, 568, 516; HRMS: [M + Na]+
calcd. for C52H54O8Na: 829.3716, found 829.3735.
3-(2,3,4-Tri-O-p-methoxybenzyl-6-O-trityl--D-galactopyranos-
yl)-1-propene (18): See experimental of compound 17. Purification
gave compound 18 (8.23 g, 10.3 mmol, 28 %). Rf: 0.33 (7:3 pentane/
Et2O); [α]D25 +9.3° (c = 0.52, CHCl3); 1H NMR (CD3CN, 400 MHz, HH-
COSY, HSQC): δ 7.47–7.41 (m, 6H, Ar), 7.38–7.20 (m, 13H, Ar), 6.99–
6.95 (m, 2H, Ar), 6.92–6.85 (m, 4H, Ar), 6.79–6.74 (m, 2H, Ar), 5.94–
5.82 (m, 1H, CH2-CH=CH2), 5.13–4.97 (m, 2H, CH2-CH=CH2), 4.78 (d,
1H, J = 10.4 Hz, CHH PMB), 4.72 (d, 1H, J = 11.3 Hz, CHH PMB), 4.67
(d, 1H, J = 10.7 Hz, CHH PMB), 4.60 (d, 1H, J = 11.3 Hz, CHH PMB),
4.51 (d, 1H, J = 10.5 Hz, CHH PMB), 4.27 (d, 1H, J = 10.7 Hz, CHH
PMB), 3.93 (dd, 1H, J = 2.9, 1.1 Hz, H-4), 3.82–3.71 (m, 9H, 3 × CH3
PMB), 3.63–3.54 (m, 2H, H-3, H-5), 3.43 (t, 1H, J = 9.3 Hz, H-2), 3.34–
3.19 (m, 2H, H-1, CHH-6), 2.89 (dd, 1H, J = 9.3, 5.6 Hz, CHH-6), 2.60–
2.49 (m, 1H, CHH-CH=CH2), 2.23–2.11 (m, 2H, CHH-CH=CH2); 13C-
APT NMR (CD3CN, 101 MHz, HSQC): δ = 160.3, 160.2, 160.1, 145.1
(Cq Ar), 136.5 (CH2-CH=CH2), 132.0, 131.9, 131.9 (Cq Ar), 130.7, 130.6,
130.5, 129.6, 128.8, 128.1 (Ar), 116.9 (CH2-CH=CH2), 114.7, 114.5,
114.4 (Ar), 87.5 (Cq Trt), 85.2 (C-3), 79.7 (C-1), 78.9 (C-2), 78.0 (C-5),
75.4 (C-4), 75.3, 74.9, 72.3 (CH2 PMB), 64.7 (CH2-6), 55.9, 55.9 (CH3
PMB), 37.1 (CH2-CH=CH2); FT-IR (neat, cm–1): 2907, 1613, 1583, 1513,
1491, 1449, 1362, 1302, 1248, 1173, 1076, 1034, 915, 821, 747, 707,
633, 518; HRMS: [M + Na]+ calcd. for C52H54O8Na: 829.3716, found
829.3740.
4-(2,3,4-Tri-O-p-methoxybenzyl-6-O-trityl-α-D-galactopyranos-
yl)-butanoic Acid (19): Compound 17 (15.2 g, 18.8 mmol,
1.0 equiv.) was co-evaporated with toluene (2 ×) under an argon
atmosphere before being dissolved in dry DCE (0.19 L). Methyl
acrylate (4.8 mL, 53 mmol, 2.8 equiv.), CuI (0.54 g, 2.8 mmol,
0.15 equiv.) and Grubbs 2nd generation catalyst (0.63 g, 0.74 mmol,
0.04 equiv.) were added and the flask was covered in aluminum foil.
The suspension was heated to 50 °C for 48 hours, after which it was
concentrated in vacuo and co-evaporated with toluene (2 ×) under
an argon atmosphere. The obtained residue was dissolved in dry
DCE (0.10 L) and cooled to 0 °C. Two empty balloons were placed
on the flask, followed by the addition of RuCl3 (0.74 g, 3.6 mmol,
0.19 equiv.) and NaBH4 (2.3 g, 61 mmol, 3.2 equiv.). Methanol
(15 mL, 0.37 mol, 20 equiv.) was carefully added to the suspension
over 20 minutes, after which the mixture was warmed-up up to
room temperature over 30 minutes. The mixture was subsequently
heated to 45 °C for 6 hours. The reaction mixture was cooled to
room temperature, diluted with brine and extracted with DCM (3 ×).
The combined organic layers were dried with Na2SO4, filtered and
concentrated in vacuo. Purification by column chromatography
(20→70 % Et2O in pentane) gave the intermediate (11.8 g,
13.6 mmol, 73 % over two steps) of which 11.7 g (13.5 mmol,
1.0 equiv.) was dissolved in a mixture of THF/H2O (4:1, v/v, 0.14 L),
followed by the addition of LiOH (1.7 g, 41 mmol, 3.0 equiv.). The
mixture was heated to 40 °C for 30 hours. The reaction mixture was
cooled to 0 °C, acidified with 3 M HCl to pH = 4:5, diluted with H2O
and extracted with DCM (2 ×). The combined organic layers were
dried with Na2SO4, filtered and concentrated in vacuo. The title
compound was obtained (10.5 g, 12.4 mmol, 92 %). Rf: 0.84 (9:1
DCM/MeOH); [α]D25 +25.6° (c = 0.90, CHCl3); 1H NMR (CD3CN,
500 MHz, HH-COSY, HSQC): δ 7.51–7.47 (m, 6H, Ar), 7.33 (t, 6H, J =
7.4 Hz, Ar), 7.30–7.24 (m, 5H, Ar), 7.18 (d, 2H, J = 8.5 Hz, Ar), 7.10
(d, 2H, J = 8.6 Hz, Ar), 6.92 (d, 2H, J = 8.6 Hz, Ar), 6.90–6.84 (m, 4H,
Ar), 4.59–4.46 (m, 5H, 2 × CH2 PMB, 1 × CHH PMB), 4.39 (d, 1H, J =
11.1 Hz, CHH PMB), 4.04–3.97 (m, 1H, H-5), 3.94–3.90 (m, 1H, H-4),
3.84–3.77 (m, 10H, H-1, 3 × CH3 PMB), 3.76 (dd, 1H, J = 6.9, 2.8 Hz,
H-3), 3.69–3.64 (m, 1H, H-2), 3.64–3.58 (m, 1H, CHH-6), 3.24 (dd, 1H,
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J = 10.5, 3.4 Hz, CHH-6), 2.38 (t, 2H, J = 7.0 Hz, CH2-9), 1.83–1.68
(m, 2H, CHH-7, CHH-8), 1.64–1.55 (m, 2H, CHH-7, CHH-8); 13C-bbdec
NMR (CD3CN, 126 MHz, HSQC): δ = 175.7 (C=O), 160.5, 160.4, 160.3,
145.5 (Cq Ar), 132.2, 132.0, 132.0, 130.6, 130.4, 130.1, 129.7, 128.8,
128.0, 114.9, 114.8, 114.8 (Ar), 87.6 (Cq Trt), 77.4 (C-2, C-3), 75.6 (C-
4), 73.7 (C-5), 73.3 (CH2 PMB), 71.7 (C-1), 63.0 (CH2-6), 56.1, 56.1 (CH3
PMB), 34.4 (CH2-9), 27.8, 22.4 (CH2-7, CH2-8); FT-IR (neat, cm–1): 2937,
1707, 1612, 1513, 1449, 1302, 1248, 1173, 1087, 1034, 821, 707, 633;
HRMS: [M + Na]+ calcd. for C53H56O10Na: 875.37657, found
875.37656.
4-(2,3,4-Tri-O-p-methoxybenzyl-6-O-trityl--D-galactopyranos-
yl)-butanoic Acid (20): Allyl 18 (8.0 g, 9.9 mmol, 1.0 equiv.) was
co-evaporated with toluene (2 ×) under an argon atmosphere be-
fore being dissolved in dry DCE (0.10 L). Methyl acrylate (2.6 mL,
29 mmol, 2.9 equiv.), CuI (0.29 g, 1.5 mmol, 0.15 equiv.) and Grubbs
2nd generation catalyst (0.34 g, 0.40 mmol, 0.04 equiv.) were added
and the flask was covered in aluminum foil. The suspension was
heated to 50 °C for 48 hours, after which it was concentrated in
vacuo and co-evaporated with toluene (2 ×) under an argon atmos-
phere. The obtained residue was dissolved in dry DCE (50 mL) and
cooled to 0 °C. Two empty balloons were placed on the flask, fol-
lowed by the addition of RuCl3 (0.39 g, 1.9 mmol, 0.19 equiv.) and
NaBH4 (1.2 g, 32 mmol, 3.2 equiv.). Methanol (8.0 mL, 0.18 mol,
20 equiv.) was carefully added to the suspension over 30 minutes,
after which the mixture was warmed-up up to room temperature
over 15 minutes. The mixture was subsequently heated to 45 °C for
5 hours. The reaction mixture was cooled to room temperature,
diluted with brine and extracted with DCM (3 ×). The combined
organic layers were dried with Na2SO4, filtered and concentrated in
vacuo. NMR analysis showed still 20 % alkene present, therefore the
2nd step was repeated using the same reaction conditions and
heated for 7 hours. Purification by column chromatography
(20→70 % Et2O in pentane) afforded the intermediate (5.8 g,
6.7 mmol, 68 % over two steps), which was was dissolved in a mix-
ture of THF/H2O (4:1, v/v, 65 mL), followed by the addition of LiOH
(0.85 g, 20 mmol, 3.0 equiv.). The mixture was heated to 40 °C for
30 hours. The reaction mixture was cooled to 0 °C, acidified with
3 M HCl to pH = 4:5, diluted with H2O and extracted with DCM
(2 ×). The combined organic layers were dried with Na2SO4, filtered
and concentrated in vacuo. The title compound was obtained (5.5 g,
6.4 mmol, 96 %). Rf: 0.89 (9:1 DCM/MeOH); [α]D25 +3.6° (c = 0.53,
CHCl3); 1H NMR (CDCl3, 400 MHz, HH-COSY, HSQC): δ 7.44–7.39 (m,
6H, Ar), 7.34–7.20 (m, 13H, Ar), 7.09–7.04 (m, 2H, Ar), 6.93–6.82 (m,
4H, Ar), 6.77–6.71 (m, 2H, Ar), 4.84 (d, 1H, J = 10.4 Hz, CHH PMB),
4.73 (d, 1H, J = 11.3 Hz, CHH PMB), 4.68–4.60 (m, 2H, CH2 PMB),
4.54 (d, 1H, J = 10.5 Hz, CHH PMB), 4.45 (d, 1H, J = 11.3 Hz, CHH
PMB), 3.89 (dd, 1H, J = 2.7, 1.0 Hz, H-4), 3.82 (s, 3H, CH3 PMB), 3.80–
3.76 (m, 6H, 2 × CH3 PMB), 3.60–3.41 (m, 3H, H-2, H-2, H-3, CHH-6),
3.31 (t, 1H, J = 6.2 Hz, H-5), 3.17–3.06 (m, 2H, H-1, CHH-6), 2.34 (t,
2H, J = 7.2 Hz, CH2-9), 1.93–1.81 (m, 2H, CHH-8, CHH-7), 1.74–1.62
(m, 1H, CHH-8), 1.52–1.42 (m, 1H, CHH-7); 13C-APT NMR (CDCl3,
101 MHz, HSQC): δ = 179.2 (C=O), 159.4, 159.3, 159.1, 144.1, 131.0,
130.8, 130.7 (Cq Ar), 130.0, 129.8, 129.3, 128.8, 128.0, 127.1, 113.9,
113.6 (Ar), 86.9 (Cq Trt), 84.7 (C-3), 79.4 (C-1), 78.7 (C-2), 77.6 (C-5),
75.2, 73.9 (CH2 PMB), 73.9 (C-4), 72.1 (CH2 PMB), 63.3 (CH2-6), 55.4,
55.4, 55.4 (CH3 PMB), 33.9 (CH2-9), 31.0 (CH2-7), 21.1 (CH2-8); FT-IR
(neat, cm–1): 2935, 1707, 1612, 1586, 1513, 1449, 1302, 1247, 1173,
1075, 1033, 821, 748, 706, 633; HRMS: [M + Na]+ calcd. for
C53H56O10Na: 875.37657, found 875.37650.
Nα-Fmoc-Nε-[butan-4-(2,3,4-tri-O-p-methoxybenzyl-6-O-trityl-α-
D-galactopyranosyl)-amide]-L-lysine (3): Compound 19 (4.3 g,
5.0 mmol, 1.0 equiv.) and Fmoc-L-lysine-OMe (2.5 g, 6.0 mmol,
1.2 equiv.) were dissolved in DMF (25 mL). HCTU (2.5 g, 6.0 mmol,
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1.2 equiv.) and DIPEA (2.6 mL, 15 mmol, 3.0 equiv.) were added and
the solution was stirred for 2 hours. The reaction mixture was di-
luted with EtOAc and washed with 1 M HCl (1 ×), sat. aq. NaHCO3
(1 ×), brine (1 ×). The organic layer was dried with Na2SO4, filtered
and concentrated in vacuo. Purification by column chromatography
(40→80 % EtOAc in pentane) gave the intermediate (5.5 g,
4.5 mmol, 90 %) as an oil, of which 4.8 g (4.0 mmol, 1.0 equiv.) was
dissolved in THF (55 mL) and cooled to 0 °C. An aqueous solution
of LiOH (0.30 M, 27 mL, 8.1 mmol, 2.0 equiv.) was added and the
suspension was stirred vigorously for 1 hour, after which the ob-
tained solution was acidified by the addition of 1 M HCl to pH = 5–
6 and diluted with brine. The mixture was extracted with EtOAc
(1 ×) and the organic layer was dried with Na2SO4, filtered and con-
centrated in vacuo. After purification by column chromatography
(2→6 % MeOH in DCM), the title compound (2.2 g, 1.8 mmol, 46 %)
was obtained as a white foam. Rf: 0.70 (9:1 DCM/MeOH); [α]D25 +15.8°
(c = 1.1, CHCl3); 1H NMR (CD3CN, 500 MHz, HH-COSY, HSQC): δ 7.80
(d, 2H, J = 7.4 Hz, Ar), 7.64 (d, 2H, J = 7.1 Hz, Ar), 7.46–7.36 (m, 8H,
Ar), 7.34–7.17 (m, 13H, Ar), 7.10 (d, 2H, J = 8.3 Hz, Ar), 7.04 (d, 2H,
J = 8.4 Hz, Ar), 6.84 (dd, 6H, J = 23.1, 8.0 Hz, Ar), 6.23 (br, 1H, NH),
5.92 (br, 1H, NHFmoc), 4.51–4.38 (m, 5H, 2 × CH2 PMB, 1 × CHH
PMB), 4.38–4.29 (m, 3H, CHH PMB, CH2 Fmoc), 4.21 (t, 1H, J = 6.7 Hz,
CH Fmoc), 4.11 (br, 1H, CH L-Lys), 3.97–3.90 (m, 1H, H-5), 3.88–3.82
(m, 1H, H-4), 3.82–3.73 (m, 9H, 3 × CH3 PMB), 3.73–3.65 (m, 2H,
H-1, H-3), 3.60–3.48 (m, 2H, H-2, CHH-6), 3.23–3.07 (m, 3H, CHH-6,
CH2 ε-L-Lys), 2.17–2.10 (m, 2H, CH2-9), 1.84–1.27 (m, 10H, 2 × CH2-
7/8, 3 × CH2 /γ/δ-L-Lys); 13C-bbdec NMR (CD3CN, 126 MHz, HSQC):
δ = 174.1, 160.7 (C=O), 160.5, 160.5, 145.6, 145.4, 145.4, 142.4, 132.4,
132.1 (Cq Ar), 130.8, 130.5, 130.3, 129.9, 129.0, 128.9, 128.3, 128.2,
126.4, 121.1, 115.0, 114.9 (Ar), 87.7 (Cq Trt), 77.5, 77.3 (C-2, C-3), 75.6
(C-4), 74.0 (C-5), 73.4, 73.3, 73.2 (CH2 PMB), 71.7 (C-1), 67.6 (CH2
Fmoc), 63.0 (CH2-6), 56.2 (CH3 PMB), 55.2 (CH L-Lys), 48.4 (CH Fmoc),
39.7 (CH2 ε-L-Lys), 37.1 (CH2-9), 32.3, 30.1, 28.2, 23.8, 23.4 (CH2-7/8,
3 × CH2 /γ/δ-L-Lys); FT-IR (neat, cm–1): 2935, 1720, 1612, 1513,
1449, 1302, 1248, 1174, 1088, 1034, 822, 761, 743, 707, 633; LC-MS:
Rt = 7.68 min (Vydac 219TP 5 μm Diphenyl, 50–90 % MeCN, 21 min
run); ESI-MS (m/z): [M + Na]+ calcd. for C74H78N2O13Na: 1225.5,
found 1225.5; HRMS: [M + H]+ calcd. for C74H79O13N2: 1203.55767,
found 1203.55754.
Nα-Fmoc-Nε-[butan-4-(2,3,4-tri-O-p-methoxybenzyl-6-O-trityl--
D-galactopyranosyl)-amide]-L-lysine (4): Compound 20 (3.4 g,
4.0 mmol, 1.0 equiv.) and Fmoc-L-lysine-OMe (2.0 g, 4.8 mmol,
1.2 equiv.) were dissolved in DMF (20 mL). HCTU (2.0 g, 4.8 mmol,
1.2 equiv.) and DIPEA (2.1 mL, 12 mmol, 3.0 equiv.) were added and
the solution was stirred for 2 hours. The reaction mixture was di-
luted with EtOAc and washed with 1 M HCl (1 ×), sat. aq. NaHCO3
(1 ×), brine (1 ×). The organic layer was dried with Na2SO4, filtered
and concentrated in vacuo. Purification by column chromatography
(30→80 % EtOAc in pentane) gave the intermediate (4.5 g,
3.7 mmol, 93 %) as an oil, of which 4.0 g (3.3 mmol, 1.0 equiv.) was
dissolved in THF (37 mL) and cooled to 0 °C. An aqueous solution
of LiOH (0.30 M, 22 mL, 6.6 mmol, 2.0 equiv.) was added and the
suspension was stirred vigorously for 75 minutes, after which the
obtained solution was acidified by the addition of 1 M HCl to
pH = 5–6 and diluted with brine. The mixture was extracted with
EtOAc (2 ×) and the organic layer was dried with Na2SO4, filtered
and concentrated in vacuo. After purification by column chroma-
tography (2→8 % MeOH in DCM), the title compound (1.9 g,
1.6 mmol, 48 %) was obtained as a white foam. Rf: 0.64 (9:1 DCM/
MeOH); [α]D25 +35.6° (c = 0.41, CHCl3); 1H NMR (CDCl3, 400 MHz, HH-
COSY, HSQC): δ 7.74 (d, 2H, J = 7.6 Hz, Ar), 7.60 (t, 2H, J = 7.2 Hz,
Ar), 7.44–7.33 (m, 8H, Ar), 7.33–7.18 (m, 15H, Ar), 7.05–6.99 (m, 2H,
Ar), 6.93–6.87 (m, 2H, Ar), 6.87–6.81 (m, 2H, Ar), 6.76–6.69 (m, 2H,
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Ar), 5.78–5.67 (m, 2H, NH, NHFmoc), 4.84 (d, 1H, J = 10.5 Hz, CHH
PMB), 4.74 (d, 1H, J = 11.2 Hz, CHH PMB), 4.65 (s, 2H, CH2 PMB),
4.55 (d, 1H, J = 10.5 Hz, CHH PMB), 4.44 (d, 1H, J = 11.3 Hz, CHH
PMB), 4.36 (d, 2H, J = 7.2 Hz, CH2 Fmoc), 4.33–4.25 (m, 1H, CH
L-Lys), 4.20 (t, 1H, J = 7.1 Hz, CH Fmoc), 3.84 (d, 1H, J = 2.8 Hz,
H-4), 3.83–3.73 (m, 9H, 3 × CH3 PMB), 3.63 (t, 1H, J = 9.3 Hz, H-2),
3.50 (dd, 1H, J = 9.3, 2.8 Hz, H-3), 3.43 (dd, 1H, J = 9.6, 6.4 Hz, CHH-
6), 3.32 (t, 1H, J = 6.2 Hz, H-5), 3.19–3.10 (m, 2H, H-1, CHH ε-L-Lys),
3.10–2.95 (m, 2H, CHH-6, CHH ε-L-Lys), 2.30–2.11 (m, 2H, CH2-9),
1.92–1.37 (m, 6H, CH2-7, CH2-8, 1 × CH2 /γ/δ-L-Lys), 1.36–1.09 (m,
4H, 2 × CH2 /γ/δ-L-Lys); 13C-APT NMR (CDCl3, 101 MHz, HSQC): δ =
174.0, 159.3 (C=O), 159.3, 159.2, 156.1, 144.1, 143.9, 141.4, 130.6,
130.4 (Cq Ar), 130.0, 129.3, 128.7, 128.0, 127.8, 127.2, 127.2, 125.3,
120.0, 113.9, 113.9, 113.6 (Ar), 87.0 (Cq Trt), 84.5 (C-3), 80.2 (C-1),
78.5 (C-2), 77.7 (C-5), 75.2 (CH2 PMB), 74.0 (C-4), 73.9, 72.2 (CH2
PMB), 67.0 (CH2 Fmoc), 63.6 (CH2-6), 55.4, 55.3 (CH3 PMB), 53.6
(CH L-Lys), 47.2 (CH Fmoc), 38.9 (CH2 ε-L-Lys), 36.4 (CH2-9), 31.7 (CH2
/γ/δ-L-Lys), 30.3 (CH2-7), 28.8, 22.9 (CH2 /γ/δ-L-Lys), 21.8 (CH2-8);
FT-IR (neat, cm–1): 2935, 1717, 1612, 1586, 1512, 1449, 1302, 1246,
1173, 1153, 1074, 1032, 900, 821, 760, 735, 704, 651, 633, 621, 541,
516; LC-MS: Rt = 7.96 min (Vydac 219TP 5 μm Diphenyl, 50–90 %
MeCN , 21 m in run ) ; E S I -MS (m / z ) : [M + Na ] + ca l cd . for
C74H78N2O13Na: 1225.5, found 1225.6; HRMS: [M + H]+ calcd. for
C74H79O13N2: 1203.55767, found 1203.55765.
1,3,4,6-Tetra-O-acetyl-2-deoxy-2-tetrachlorophthalimido-α-D-
glucopyranoside (21): Glucosamine hydrochloride (21.6 g,
100 mmol, 1.0 equiv.) was added to a solution of sodium methoxide
(1.0 M in MeOH, 0.10 L, 1.0 equiv.) at room temperature and the
obtained solution was stirred for 10 minutes, followed by the addi-
tion of tetrachlorophthalic anhydride (14.3 g, 50.0 mmol, 0.5 equiv.).
After 20 minutes, additional tetrachlorophthalic anhydride (14.3 g,
50.0 mmol, 0.5 equiv.) and Et3N (10 mL, 0.10 mol, 1.0 equiv.) were
added and the reaction was stirred at 50 °C for 20 minutes. The
mixture was concentrated in vacuo. The residue was dissolved in
pyridine (98 mL), followed by slow addition of Ac2O (0.15 L, 1.6 mol,
16.0 equiv.). The resulting mixture was stirred for 16 hours at room
temperature, after which it was poured into ice water (0.15 L) and
extracted with DCM (3 ×). The combined organic layers were subse-
quently washed with a 1 M HCl (2 ×), sat. aq. NaHCO3 (2 ×) and
brine (1 ×). The organic layer was dried with MgSO4, filtered, con-
centrated in vacuo and co-evaporated with toluene (1 ×). Recrystal-
lization in MeOH yielded the title compound (31.4 g, 51.0 mmol,
51 %) as a white solid. Rf: 0.6 (3:2 pentane/EtOAc); [α]D25 = +96.6°
(c = 1.0, DCM); 1H NMR (CDCl3, 400 MHz, HH-COSY, HSQC): δ = 6.48
(dd, 1H, J = 11.5, 9.1 Hz, H-3), 6.24 (d, 1H, J = 3.4 Hz, H-1), 5.15 (t,
1H, J = 10.1, 9.0 Hz, H-4), 4.70 (dd, 1H, J = 11.5, 3.4 Hz, H-2), 4.38–
4.27 (m, 2H, H-5, CHH-6), 4.13 (dd, 1H, J = 12.2, 1.8 Hz, CHH-6), 2.11
(s, 3H, CH3 Ac), 2.08 (s, 3H, CH3 Ac), 2.05 (s, 3H, CH3 Ac), 1.90 (s, 3H,
CH3 Ac); 13C-APT NMR (CDCl3, 101 MHz, HSQC): δ = 170.8, 169.9,
169.8, 169.6 (C=O), 140.9 (Cq Ar), 130.3, 126.8 (C-Cl), 90.6 (C-1), 70.4
(C-5), 69.3 (C-4), 67.0 (C-3), 61.5 (CH2-6), 53.5 (C-2), 21.1, 20.9, 20.8,
20.8 (CH3 Ac); FT-IR (neat, cm–1): 2965, 1750, 1731, 1385, 1370, 1219,
1154, 1081, 1040, 1015, 922, 794, 752, 740, 603, 540, 485; HRMS:
[M + Na]+ calcd. for C22H19Cl4NO11Na 635.9610, found 635.9617.
3-C-(3,4,6-Tri-O-acetyl-2-deoxy-2-tetrachlorophthalimido--D-
glucopyranosyl)-1-propene (22): Compound 21 (24.6 g,
40.0 mmol, 1.0 equiv.) was co-evaporated with toluene (3 ×) under
an argon atmosphere. The residue was dissolved in acetonitrile
(0.24 L) and cooled to 0 °C. Allyltrimethylsilane (32 mL, 0.20 mol,
5.0 equiv.) was added, followed by slow addition of TMSOTf (7.2 mL,
40 mmol, 1.0 equiv.) and BF3·OEt2 (25 mL, 0.20 mol, 5.0 equiv.). The
yellow suspension was sonicated for 90 minutes and stirred for an
additional hour at room temperature. The resulting brown solution
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was cooled to 0 °C and quenched with Et3N to pH = 7. The reaction
was diluted with EtOAc, washed with sat. aq. NaHCO3 (1 ×) and
brine (1 ×). The organic layer was dried with Na2SO4, filtered and
concentrated in vacuo. Purification by column chromatography
(10→50 % Et2O in pentane) yielded the title compound (13.9 g,
23.2 mmol, 58 %) as a white foam. Rf: 0.5 (1:1 pentane/Et2O); [α]D25 =
+74.4° (c = 1.0, DCM); 1H NMR (CDCl3, 400 MHz, HH-COSY, HSQC):
δ 5.78–5.65 (m, 2H, H-3, CH2-CH=CH2), 5.12 (t, 1H, J = 10.2 Hz, H-4),
5.00–4.87 (m, 2H, CH2-CH=CH2), 4.47–4.34 (m, 1H, H-1), 4.27 (dd, 1H,
J = 12.3, 4.9 Hz, CHH-6), 4.21 (t, 1H, J = 10.2 Hz, H-2), 4.10 (dd, 1H,
J = 12.3, 2.3 Hz, CHH-6), 3.79–3.73 (m, 1H, H-5), 2.26 (t, 2H, J =
6.8 Hz, CH2-CH=CH2), 2.09 (s, 3H, CH3 Ac), 2.01 (s, 3H, CH3 Ac), 1.86
(s, 3H, CH3 Ac); 13C-APT NMR (CDCl3, 101 MHz, HSQC): δ = 170.9,
170.8, 169.6, 163.5, 162.8 (C=O), 140.9, 140.6 (Cq Ar), 132.5 (CH2-
CH=CH2), 130.2, 130.0, 127.1, 126.8 (C-Cl), 118.1 (CH2-CH=CH2), 75.8
(C-5), 74.0 (C-1), 71.9 (C-3), 69.0 (C-4), 62.4 (CH2-6), 55.3 (C-2), 36.8
(CH2-CH=CH2), 20.9, 20.7, 20.6 (CH3 Ac); FT-IR (neat, cm–1): 2957,
1782 1746, 1724, 1384, 1370, 1352, 1226, 1150, 1047, 908, 791, 753,
740, 603; HRMS: [M + H]+ calcd. for C23H22Cl4NO9 596.0043, found
596.0045.
3-C-(2-Deoxy-2-tetrachlorophthalimido--D-glucopyranosyl)-1-
propene (23): Acetyl chloride (1.6 mL, 23 mmol, 0.8 equiv.) was
added to a solution of compound 22 (17.1 g, 28.7 mmol, 1.0 equiv.)
in a mixture of DCM/MeOH (1:4 v/v, 0.29 L) at 0 °C. After stirring for
1 hour, the reaction mixture was warmed-up to room temperature
and stirred for 72 hours. The mixture was diluted with toluene
(30 mL) and concentrated in vacuo. The residue was co-evaporated
with toluene (2 ×) and purified by column chromatography
(1→10 % MeOH in DCM) to obtain the title compound (12.7 g,
26.9 mmol, 94 %) as a white solid. Rf: 0.5 (1:9 MeOH/DCM); [α]D20 =
+34.7° (c = 1.0, DCM); 1H NMR (CDCl3, 400 MHz, HH-COSY, HSQC):
δ 5.76–5.63 (m, 1H, CH2-CH=CH2), 4.88 (t, 2H, CH2-CH=CH2), 4.24 (t,
1H, J = 10.5, 8.8 Hz, H-3), 4.21–4.13 (m, 1H, H-1), 3.91 (t, 1H, J =
10.3, 10.3 Hz, H-2), 3.86–3.77 (m, 2H, CH2-6), 3.56 (t, 1H, J = 9.2,
9.2 Hz, H-4), 3.52–3.43 (m, 3H, OH), 3.40 (dt, 1H, J = 9.6, 3.2, 3.2 Hz,
H-5), 2.27–2.10 (m, 2H, CH2-CH=CH2); 13C-APT NMR (CDCl3, 101 MHz,
HSQC): δ = 163.9, 163.8 (C=O), 140.4, 140.4 (Cq Ar), 133.4 (CH2-CH=
CH2), 130.1, 129.7, 127.3, 127.3 (C-Cl), 117.5 (CH2-CH=CH2), 79.2
(C-5), 74.2 (C-1), 71.8 (C-3), 71.4 (C-4), 62.0 (CH2-6), 57.5 (C-2), 37.2
(CH2-CH=CH2); FT-IR (neat, cm–1): 3378, 2929, 1779, 1718, 1387,
1370, 1351, 1299, 1202, 1142, 1085, 1000, 919, 791, 753, 740, 643;
HRMS: [M + Na]+ calcd. for C17H15Cl4NO6Na 491.9551, found
491.9551.
3-C-(4,6-Di-O-benzylidene-2-deoxy-2-tetrachlorophthalimido-
-D-glucopyranosyl)-1-propene (24): Compound 23 (10.6 g,
22.5 mmol, 1.0 equiv.) was co-evaporated with toluene (3 ×) under
an argon atmosphere. The residue was dissolved in a mixture of
DMF/acetonitrile (9:1 v/v, 113 mL). Benzylaldehyde dimethyl acetal
(6.9 mL, 45 mmol, 2.0 equiv.) and p-toluenesulfonic acid (0.43 g,
2.3 mmol, 0.1 equiv.) were added and the mixture was heated to
60 °C. After stirring overnight, the mixture was cooled to 0 °C and
quenched with Et3N to pH = 7. The solution was diluted with EtOAc
and the organic layer washed with H2O (3 ×), dried with MgSO4,
filtered and concentrated in vacuo. Purification by column chroma-
tography (10→40 % Et2O in pentane) gave compound 24 (11.0 g,
19.7 mmol, 87 %) as a white solid. Rf: 0.8 (1:1 pentane/Et2O); [α]D20 =
+17.5° (c = 1.0, DCM); 1H NMR (CDCl3, 400 MHz, HH-COSY, HSQC):
δ 7.39–7.27 (m, 5H, Ar), 5.78–5.64 (m, 1H, CH2-CH=CH2), 5.49 (s, 1H,
CH benzylidene), 4.94 (t, 2H, J = 9.4 Hz, CH2-CH=CH2), 4.60 (t, 1H,
J = 10.2, 9.0 Hz, H-3), 4.33 (dd, 1H, J = 10.2, 4.7 Hz, CHH-6), 4.30–
4.22 (m, 1H, H-1), 4.05 (t, 1H, J = 10.2 Hz, H-2), 3.70 (t, 1H, J =
10.1 Hz, CHH-6), 3.64–3.55 (m, 1H, H-5), 3.48 (t, 1H, J = 9.1 Hz, H-4),
3.19 (s, 1H, OH), 2.30–2.17 (m, 2H, CH2-CH=CH2); 13C-APT NMR
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(CDCl3, 101 MHz, HSQC): δ = 163.7, 163.2 (C=O), 140.4, 140.3 (C-Cl),
136.9 (Cq Ar), 133.0 (CH2-CH=CH2), 130.1, 129.8 (C-Cl), 129.3, 128.3
(Ar), 127.1, 127.1 (C-Cl), 126.0 (Ar), 117.7 (CH2-CH=CH2), 101.7 (CH
benzylidene), 82.5 (C-4), 75.0 (C-1), 70.1 (C-5), 68.8 (CH2-6), 68.6
(C-3), 57.1 (C-2), 37.0 (CH2-CH=CH2); FT-IR (neat, cm–1): 3485, 2864,
1779, 1720, 1371, 1351, 1300, 1203, 1124, 1096, 988, 918, 790, 753,
740, 699, 643; HRMS: [M + H]+ calcd. for C24H20Cl4NO6 558.0039,
found 558.0047.
3-C-(2-Deoxy-2-N-acetyl-4,6-O-di-benzylidene--D-glucopyran-
osyl)-1-propene (25): To a solution of compound 24 (3.8 g,
6.8 mmol, 1.0 equiv.) in EtOH (70 mL) was added ethylenediamine
(23 mL, 0.34 mol, 50 equiv.) and the reaction was heated to 90 °C.
After 16 hours, the reaction mixture was diluted with toluene and
concentrated in vacuo. The residue was co-evaporated with toluene
(3 ×) and embedded on silica gel. Purification by column chroma-
tography (2→5 % MeOH in DCM) gave 3-C-(4,6-di-O-benzyl-
idene-2-deoxy-2-amine--D-glucopyranosyl)-1-propene (1.92 g,
6.59 mmol) as a yellow solid. Rf: 0.42 (1:9 MeOH/DCM). The obtained
amine (1.92 g, 6.59 mmol, 1.0 equiv.) was dissolved in a mixture of
THF/H2O (1:1 v/v, 50 mL). Sodium bicarbonate (5.6 g, 66 mmol,
10 equiv.) and Ac2O (3.1 mL, 33 mmol, 5.0 equiv.) were added. The
mixture was stirred at room temperature for 4 days, after which the
reaction mixture was diluted with EtOAc. The obtained suspension
was filtered and the obtained pure title compound was collected
as a white solid. The filtrate was washed with sat. aq. NaHCO3 (1 ×)
and brine (1 ×). The organic layer was dried with MgSO4, filtered
and concentrated in vacuo. The remaining crude product was crys-
tallized using DCM/MeOH/pentane giving compound 25. The re-
maining residue was embedded on silica and purified by column
chromatography (2→6 % MeOH in DCM). The combined title com-
pound (1.87 g, 5.63 mmol, 83 % over two steps) was collected as a
white solid. Rf: 0.5 (1:9 MeOH/DCM); [α]D20 = –38.5° (c = 0.3, MeOH);
1H NMR (MeOD, 400 MHz, HH-COSY, HSQC): δ 7.53–7.46 (m, 2H, Ar),
7.38–7.30 (m, 3H, Ar), 5.93–5.80 (m, 1H, CH2-CH=CH2), 5.59 (s, 1H,
CH benzylidene), 5.03 (t, 2H, J = 17.5, 8.7 Hz, CH2-CH=CH2), 4.25
(dd, 1H, J = 10.3, 5.0 Hz, CHH-6), 3.75 (q, 2H, J = 11.5, 10.0 Hz, H-2,
CHH-6), 3.66 (t, 1H, J = 9.7, 8.9 Hz, H-3), 3.50 (t, 1H, J = 9.1 Hz, H-4),
3.47–3.34 (m, 2H, H-1, H-5), 2.41–2.29 (m, 1H, CHH-CH=CH2), 2.26–
2.13 (m, 1H, CHH-CH=CH2), 1.99 (s, 3H, CH3 Ac); 13C-APT NMR
(MeOD, 101 MHz, HSQC): δ = 173.7 (C=O), 139.2 (Cq Ar), 135.7
(CH2-CH=CH2), 129.9, 129.0, 127.5 (Ar), 117.2 (CH2-CH=CH2), 102.9
(CH benzylidene), 83.2 (C-4), 80.4 (C-1), 73.9 (C-3), 71.8 (C-5), 69.8
(CH2-6), 57.2 (C-2), 37.7 (CH2-CH=CH2), 22.9 (CH3 Ac); FT-IR (neat,
cm–1): 3380, 2361, 1630, 1377, 1125, 1033, 999, 698; HRMS: [M +
H]+ calcd. for C18H24NO5 334.1655, found 334.1654.
3-(2-Deoxy-2-N-acetyl-4,6-O-di-benzylidene-3-O-p-methoxy-
benzyl--D-glucopyranosyl)-1-propene (26): Alcohol 25 (1.6 g,
4.9 mmol, 1.0 equiv.) was co-evaporated with toluene (1 ×) under
an argon atmosphere, followed by the addition of dry THF (0.12 L)
and p-methoxybenzyl-2,2,2-trichloroacetimidate (3.1 mL, 15 mmol,
3.0 equiv.). The suspension was cooled to 0 °C and a solution of
TfOH in THF (0.01 M, 50 mL, 0.50 mmol, 0.10 equiv.) was added.
After 15 minutes, the mixture was warmed up to room temperature
and stirred for 3 hours. The obtained solution was neutralized with
Et3N and diluted with EtOAc and washed with sat. aq. NaHCO3 (1 ×)
and brine (1 ×). The organic layer was dried with Na2SO4, filtered
and concentrated in vacuo. The residue was embedded on silica
and purified by column chromatography (2→20 % acetone in
DCM). The title compound was obtained (1.7 g, 3.8 mmol, 78 %) as
a white solid. Rf: 0.45 (9:1 DCM/acetone); [α]D25 –58.4° (c = 0.32,
CHCl3/MeOH, 1:1); 1H NMR (CDCl3, 400 MHz, HH-COSY, HSQC):
δ 7.53–7.48 (m, 2H, Ar), 7.42–7.35 (m, 3H, Ar), 7.25–7.21 (m, 2H, Ar),
6.89–6.84 (m, 2H, Ar), 5.88–5.75 (m, 1H, CH2-CH=CH2), 5.58 (s, 1H,
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CH benzylidene), 5.15–5.00 (m, 3H, NH, CH2-CH=CH2), 4.82 (d, 1H,
J = 11.8 Hz, CHH PMB), 4.61 (d, 1H, J = 11.7 Hz, CHH PMB), 4.32 (dd,
1H, J = 10.4, 5.0 Hz, CHH-6), 3.80 (s, 3H, CH3 PMB), 3.77–3.64 (m,
4H, H-2, H-3, H-4, CHH-6), 3.51–3.44 (m, 1H, H-1), 3.44–3.37 (m, 1H,
H-5), 2.39–2.31 (m, 1H, CHH-CH=CH2), 2.28–2.18 (m, 1H, CHH-CH=
CH2), 1.90 (s, 3H, CH3 Ac); 13C-APT NMR (CDCl3, 101 MHz, HSQC):
δ = 170.3 (C=O), 159.5, 137.6 (Cq Ar), 134.4 (CH2-CH=CH2), 130.6 (Cq
Ar), 130.2, 129.1, 128.4, 126.1 (Ar), 117.2 (CH2-CH=CH2), 113.9 (Ar),
101.2 (CH benzylidene), 83.0 (C-4), 79.2 (C-1), 77.8 (C-3), 73.5 (CH2
PMB), 70.5 (C-5), 69.0 (CH2-6), 55.4 (CH3 PMB), 55.1 (C-2), 36.6 (CH2-
CH=CH2), 23.7 (CH3 Ac); FT-IR (neat, cm–1): 3277, 2871, 1651, 1615,
1555, 1514, 1454, 1371, 1302, 1249, 1172, 1132, 1102, 1034, 1015,
962, 919, 821, 749, 697, 592, 516; HRMS: [M + H]+ calcd. for
C26H32O6N: 454.22241, found 454.22225.
4-(2-Deoxy-2-N-acetyl-4,6-O-di-benzylidene-3-O-p-methoxy-
benzyl--D-glucopyranosyl)-butanoic Acid (27): Compound 26
(1.4 g, 3.1 mmol, 1.0 equiv.) was co-evaporated with toluene (2 ×)
under an argon atmosphere and dissolved in dry DCE (31 mL).
Methyl acrylate (0.78 mL, 8.6 mmol, 2.8 equiv.), CuI (90 mg,
0.47 mmol, 0.15 equiv.) and Grubbs 2nd generation catalyst (0.26 g,
0.31 mmol, 0.10 equiv.) were added and the flask was covered in
aluminum foil. The suspension was heated to 50 °C overnight, after
which it was concentrated in vacuo and co-evaporated with toluene
(3 ×) under an argon atmosphere. The residue was dissolved in dry
DCE (31 mL) and cooled to 0 °C. RuCl3 (0.12 g, 0.58 mmol,
0.19 equiv.) and NaBH4 (0.37 g, 9.8 mmol, 3.2 equiv.) were added,
and an empty balloon was placed on the flask. Methanol (2.5 mL,
61 mmol, 20 equiv.) was carefully added to the suspension over
20 minutes, after which the mixture was warmed-up up to room
temperature over 25 minutes. The mixture was subsequently
heated to 45 °C for 7 hours. The reaction mixture was cooled to
room temperature, diluted with brine, and extracted with DCM
(3 ×). The combined organic layers were dried with Na2SO4, filtered
and concentrated in vacuo. Purification by column chromatography
(8→15 % acetone in DCM) gave the intermediate (1.1 g, 2.1 mmol,
68 % over two steps), of which 1.0 g (1.0 g, 2.0 mmol, 1.0 equiv.)
was suspended in THF/H2O/MeOH (7:1:2, v/v/v, 20 mL). LiOH (0.26 g,
6.2 mmol, 3.1 equiv.) was added and the mixture was heated to
40 °C for 3 hours, after which TLC analysis showed complete conver-
sion of the starting material. The reaction was diluted with EtOAc
and acidified with 1 M HCl to pH = 6–7, followed by the extraction
of the aqueous layer with EtOAc (1 ×) and DCM (1 ×). The combined
organic layers were dried with Na2SO4, filtered and concentrated in
vacuo. The title compound was obtained (1.0 g, 2.0 mmol, quant.).
Rf: 0.45 (9:1 DCM/MeOH); [α]D25 –54.3° (c = 0.28, CHCl3/MeOH, 1:1);
1H NMR (DMSO, 400 MHz, HH-COSY, HSQC): δ 11.99 (s, 1H, OH), 7.89
(d, 1H, J = 9.0 Hz, NH), 7.47–7.34 (m, 5H, Ar), 7.18 (d, 2H, J = 8.7 Hz,
Ar), 6.85 (d, 2H, J = 8.7 Hz, Ar), 5.68 (s, 1H, CH benzylidene), 4.64 (d,
1H, J = 11.3 Hz, CHH PMB), 4.51 (d, 1H, J = 11.4 Hz, CHH PMB), 4.21
(dd, 1H, J = 10.1, 4.9 Hz, CHH-6), 3.77–3.53 (m, 7H, H-2, H-3, H-4,
CHH-6, CH3 PMB), 3.40–3.26 (m, 2H, H-1, H-5), 2.18 (t, 2H, J = 7.2 Hz,
CH2-9), 1.83 (s, 3H, CH3 Ac), 1.73–1.62 (m, 1H, CHH-8), 1.58–1.41 (m,
2H, CHH-7, CHH-8), 1.34–1.22 (m, 1H, CHH-7); 13C-APT NMR (DMSO,
101 MHz, HSQC): δ = 174.4 (C=O), 169.2, 158.6, 137.8, 130.9 (Cq Ar),
129.0, 128.7, 128.1, 126.0, 113.4 (Ar), 100.0 (CH benzylidene), 81.4
(C-4), 79.7 (C-1), 79.0 (C-3), 72.9 (CH2 PMB), 70.0 (C-5), 68.0 (CH2-6),
55.0 (CH3 PMB), 53.9 (C-2), 33.5 (CH2-9), 30.8 (CH2-7), 22.9 (CH3 Ac),
20.8 (CH2-8); FT-IR (neat, cm–1): 2870, 2428, 1725, 1597, 1516, 1489,
1366, 1302, 1274, 1251, 1223, 1172, 1136, 1109, 1088, 1041, 1020,
966, 923, 822, 747, 694, 606, 539; HRMS: [M + H]+ calcd. for
C27H34O8N1: 500.22789, found 500.22784.
Nα-Fmoc-Nε-[butan-4-(2-deoxy-2-N-acetyl-4,6-O-di-benzyl-
idene-3-O-p-methoxybenzyl--D-glucopyranosyl)-amide]-L-
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lysine (5): Acid 27 (0.97 g, 1.9 mmol, 1.0 equiv.) and Fmoc-L-lysine-
OMe (0.98 g, 2.3 mmol, 1.2 equiv.) were dissolved in DMF (20 mL),
followed by the addition of HCTU (0.96 g, 2.3 mmol, 1.2 equiv.) and
DIPEA (1.0 mL, 5.7 mmol, 3.0 equiv.). The reaction was stirred at
room temperature for 4 hours, after which Et2O was added. The
precipitate was filtered and recrystallized with MeOH/DCM/Et2O to
obtain the intermediate (1.3 g, 1.5 mmol, 78 %), of which 0.92 g
(1.1 mmol, 1.0 equiv.) was suspended in THF (21 mL). An aqueous
solution of LiOH (0.30 M, 7.1 mL, 2.1 mmol, 2.0 equiv.) was added
at room temperature and stirring was continued for 50 minutes,
before the obtained clear solution was neutralized with 1 M HCl
(2.2 mL, 2.2 mmol, 2.0 equiv.). NaHCO3 (0.36 g, 4.3 mmol, 4.0 equiv.)
and Fmoc N-hydroxysuccinimide ester (0.72 g, 2.1 mmol, 2.0 equiv.)
were added and the mixture was stirred vigorously for 2 hours.
Upon completion of the reaction determined by LC-MS, Et2O was
added at 0 °C to precipitate the crude product. After filtration, the
precipitate was purified by recrystallization (MeOH/DCM/Et2O) to
yield the title compound (0.88 g, 1.0 mmol, 91 %) as a white solid.
Rf: 0.40 (85:15 DCM/MeOH); [α]D25 +15.5° (c = 1.0, CHCl3/MeOH, 1:1);
1H NMR (MeOD/CDCl2: 1:1 v/v, 400 MHz, HH-COSY, HSQC): δ 7.80–
7.74 (m, 2H, Ar), 7.68–7.60 (m, 2H, Ar), 7.51–7.44 (m, 2H, Ar), 7.43–
7.32 (m, 5H, Ar), 7.35–7.26 (m, 2H, Ar), 7.23–7.15 (m, 2H, Ar), 6.86–
6.78 (m, 2H, Ar), 5.58 (s, 1H, CH benzylidene), 4.75 (d, 1H, J = 11.3 Hz,
CHH PMB), 4.59–4.54 (m, 1H, CHH PMB), 4.37–4.28 (m, 2H, CH2
Fmoc), 4.31–4.18 (m, 2H, CHH-6, CH Fmoc), 4.02 (dd, 1H, J = 7.0,
5.0 Hz, CH L-Lys), 3.81–3.72 (m, 4H, H-2, CH3 PMB), 3.74–3.59 (m, 3H,
H-3, H-4, CHH-6), 3.44–3.32 (m, 2H, H-1, H-5), 3.20–3.08 (m, 2H, CH2
ε-L-Lys), 2.13 (t, 2H, J = 7.6 Hz, CH2-9), 1.91 (s, 3H, CH3 Ac), 1.86–1.29
(m, 10H, CH2-7, CH2-8, 3 × CH2 /γ/δ-L-Lys); 13C-APT NMR (MeOD,
101 MHz, HSQC): δ = 178.6, 175.2, 172.6 (C=O), 160.0, 157.3, 144.9,
144.7, 142.0, 138.5, 131.5 (Cq Ar), 130.2, 129.5, 128.8, 128.3, 127.7,
126.8, 125.8, 120.5, 114.2 (Ar), 101.9 (CH benzylidene), 83.3 (C-4),
80.4 (C-3), 79.8 (C-1), 74.6 (CH2 PMB), 71.1 (C-5), 69.5 (CH2-6), 67.3
(CH2 Fmoc), 57.0 (CH L-Lys), 55.6 (CH3 PMB), 55.4 (C-2), 48.0 (CH
Fmoc), 39.8 (CH2 ε-L-Lys), 36.6 (CH2-9), 33.4, 32.0, 29.5, 25.7, 23.4
(CH2-7/8, 3 × CH2 /γ/δ-L-Lys), 23.0 (CH3 Ac), 22.6 (CH2-7/8, 3 × CH2
/γ/δ-L-Lys); FT-IR (neat, cm–1): 3286, 1638, 1547, 1513, 1451, 1370,
1249, 1176, 1135, 1088, 1030, 820, 737, 696, 621, 541; LC-MS: Rt =
7.75 min (C18 Gemini, 10–90 % MeCN, 11 min run); ESI-MS (m/z):
[M + Na]+ calcd. for C48H55N3O11Na: 872.4, found 872.4 [M + Na]+;
HRMS: [M + H]+ calcd. for C48H56O11N3: 850.39094, found 850.39103.
Acetyl-Lys(Nε-[butan-4-(α-D-mannosyl)-amide])-Lys(Nε-[butan-4-
(-D-galactosyl)-amide])-Lys(Nε-[butan-4-(α-D-galactosyl)-
amide])-Lys(N3)-Lys-NH2 (29): Tentagel S Ram resin on 100 μmol
scale was treated with 20 % piperidine in DMF for 10 min and sub-
sequently elongated with Fmoc-Lys(Boc)-OH, Fmoc-Lys(N3)-OH, 3, 4
and 2 using 2.0 equivalents of each amino acid and 2 hours cou-
pling time at 50 °C. After deprotection of the Fmoc, 50 μmol of the
resin was capped by treatment with a mixture of 20 % Ac2O in 0.1
M DIPEA in DMF. The resin was washed with DCM and treated with
the standard cleavage cocktail (TFA/TIS/H2O, 95:2.5:2.5 v/v/v,
2.0 mL) for 3 hours. The suspension was filtered and the product
was precipitated with Et2O. After purification by RP-HPLC and lyo-
philization, conjugate 29 (3.4 mg, 2.4 μmol, 5 %) was obtained as a
white solid. LC-MS: Rt = 6.88 min (C18 Gemini, 5–20 % MeCN,
15 min run); ESI-MS (m/z): [M + H]+ calcd. for C62H112N13O24: 1422.8,
found 1422.8; HRMS: [M+2H]2+ calcd. for C62H113N13O24: 711.90052,
found 711.89978.
Acetyl-Lys(Nε-[butan-4-(2-deoxy-2-N-acetyl--D-glucosyl)-
amide])-Lys(Nε-[butan-4-(α-D-mannosyl)-amide])-Lys(Nε-[butan-
4-(-D-galactosyl)-amide])-Lys(Nε-[butan-4-(α-D-galactosyl)-
amide])-Lys(N3)-Lys-NH2 (30): The previously obtained 50 μmol
pentamer on resin (see 29) was treated with a mixture of 5
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(2.0 equiv.), HCTU (2.0 equiv.), DIPEA (4.0 equiv.) in DMSO (2.0 mL) at
50 °C for 2 hours. LC-MS analysis showed the presence of pentamer.
Therefore the resin was treated with the same mixture at room
temperature overnight. After deprotection of the Fmoc, the resin
was capped by treatment with a mixture of 20 % Ac2O in 0.1 M
DIPEA in DMF. The resin was washed with DCM and treated with the
standard cleavage cocktail (TFA/TIS/H2O, 95:2.5:2.5 v/v/v, 2.0 mL) for
3urs. The suspension was filtered and the product was precipitated
with Et2O. After purification by RP-HPLC and lyophilisation, conju-
gate 30 (1.8 mg, 1.0 μmol, 2 %) was obtained as a white solid.
LC-MS: Rt = 7.33 min (C18 Gemini, 5–20 % MeCN, 15 min run); ESI-
MS (m/z): [M + H]+ calcd. for C80H143N16O31: 1824.0, found 1824.0;
HRMS: [M+2H]2+ calcd. for C80H144N16O31: 912.50862, found
912.50813.
Lys(Nε-[butan-4-(α-L-rhamnosyl)-amide])-Lys(Nε-[butan-4-(α-L-
rhamnosyl)-amide])-Lys(Nε-[butan-4-(α-L-rhamnosyl)-amide])-
Lys(Nε-[butan-4-(α-L-rhamnosyl)-amide])-Lys(Nε-[butan-4-(α-L-
rhamnosyl)-amide])-Lys(Nε-[butan-4-(α-L-rhamnosyl)-amide])-
Leu-Glu-Gln-Leu-Glu-Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-Ala-Ala-
Ala-Ala-Ala-Lys-OH (32): Tentagel S Ac resin loaded with
LEQLESIINFEKLAAAAAK on 10 μmol scale was elongated six times
with 1 (3.0 equiv., 2 hours coupling time). After cleaving from the
resin, the peptide was purified by RP-HPLC. After lyophilisation, con-
jugate 32 (2.6 mg, 0.63 μmol, 6 %) was obtained as a white solid.
UPLC-MS: Rt = 3.34 min (ACQUITY UPLC BEH C18, 5–75 % MeCN,
10 min run ) ; MALD I -TOF MS (m / z ) : [M + Na ]+ ca l cd . for
C189H324N35O65: 4124.9, found 4128.7; HRMS: [M+3H]3+ calcd. for
C189H325O65N35: 1375.44212, found 1375.44806.
Keywords: Carbohydrates · Glycoconjugates ·
Glycopeptides · Metathesis · Synthetic methods
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